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Abstract
Chronic musculoskeletal pain results in significant personal, economic, and social burden.
Early identification and intervention in those people with acute pain that are likely to
transition into a state of chronicity can prevent the onset of chronic pain before it emerges
and becomes resistant to treatment. This study investigated the potential stress biomarkers
associated with acute pain and disability and how those associations are influenced by early
life adversities.
Stress level was determined according to the plasma level of stress biomarkers (cortisol,
BDNF, TGFB1) and self-report measures of stress following musculoskeletal traumatic
events. The magnitude and direction of associations of cortisol and BDNF with selfreported stress markers provided supportive evidence for further exploration of cortisol and
BDNF as acute stress biomarkers. The results of the study also supported the moderating
role of adverse childhood experiences on the associations between self-reported distress
and stress biomarkers.
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Chapter 1

1

Introduction

The main rationale of this thesis is based on the multidimensional (biological,
psychological and social) conceptualizations of chronic pain. Understanding the effects of
the bio-psycho-social variables and their associations in the development of chronic pain
could help clinicians to identify the patients who are likely at risk of developing chronic
pain related conditions after having a non-catastrophic musculoskeletal injury. Early
recognition of the people who are at high risk could help clinicians to offer adequate and
appropriate patient care. This could in turn reduce what can amount to enormous suffering
and cost related to chronic pain conditions. To aid in the understating about the complex,
multifactorial nature of chronic pain, this chapter provides an overview of the suggested
mechanisms that are involved in the development of chronic pain. It starts by exploring the
personal, social and financial impacts of chronic pain. The possible role of stress markers
in the acute pain setting and how it can shape the development of chronic physical and
psychological conditions are also discussed. The possible moderating effects of adverse
childhood experiences on the associations between stress biomarkers and pain-related
cognitions are also included in this chapter.
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1.1 Prevalence and significance of chronic musculoskeletal
pain
The personal and social burden of chronic pain is increasingly being recognized. Chronic
non cancer pain is the most common sequela of non-catastrophic musculoskeletal injuries.
The International Association for the study of pain defined chronic pain as persistent or
periodic pain experienced almost every day for a period of about six month (Phillips, 2009).
In many cases the onset of that pain can be traced back to a trauma such as a sports injury,
a workplace injury, aging, a car crash, surgery or even a chronic condition, such as arthritis
or diabetes. About 1 in 5 individuals in Canada live with some forms of chronic pain
(Moulin, Clark, Speechley, & Morley-Forster, 2002) and pain accounts for 80% of all
physician visits (Gatchel, Robert J.; Peng, Yuan Bo; Peters, Madelon L.; Fuchs, Perry N.;
Turk, 2007). Current best estimates following acute traumatic neck pain indicate that about
50% will continue to report persistent problems even after 1 year (Carroll et al., 2008). The
economic impact of chronic pain is larger than other health conditions as disability tends
to peak in middle age, adversely affecting adults during their peak productivity years
(Gaskin & Richard, 2012; Phillips, 2009). It is estimated that the cost of chronic pain in
North America ($560 to $635 billion) is greater than the costs of heart disease ($309
billion), neoplasm ($243 billion) and diabetes ($127 billion) (Gaskin & Richard, 2012 ;
Gatchel, McGeary, McGeary, & Lippe, 2014).
"Chronic Pain" is considered as one of the major public health problems of the
industrialized world (Gatchel et al., 2014). Approximately 60% of people in Canada who
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are diagnosed with chronic pain eventually lose their job (Lynch, 2011). In Sweden the
loss of production due to absence from work as a result of chronic pain accounts for 91%
of the total socioeconomic costs (Phillips, 2009). A study by Dennis (2006) reported about
1 million cumulative days of sick leave annually in Denmark as a result of chronic pain
(Eriksen, Sjøgren, Bruera, Ekholm, & Rasmussen, 2006; Phillips, 2009). In Canada, the
mean sick leave due to chronic pain is 28.5 days per year (Phillips, 2009; Lynch, 2011). A
Canadian study (STOP-PAIN) estimated direct (drug treatment) and indirect costs (lost
labor time) relating to chronic pain and it was $1,462 per patient per month in Canada
(Guerriere et al., 2010).
Much of this burden is due to the high level of activity limitations among people with
chronic musculoskeletal pain. Chronic pain is a "silent epidemic" as there is too little
awareness of the real prevalence of chronic pain and it is impossible to count the costs of
reduced quality of life, job loss, ineffective and inadequate management of pain and
increased rates of mental disorders (Sessle, 2012). However the problem is not confined to
the economic burden. It can also lead to enormous suffering and reduced quality of life.
Chronic pain and musculoskeletal disorders have been associated with poorest quality of
life indices (Sprangers et al., 2000).Several studies have found that health related quality
of life (HRQL) in patients with chronic non cancer pain is within the lowest range when
compared to their age and sex matched healthy controls. In a study of over 150 patients
attending a chronic pain clinic in Denmark, there were markedly reduced Medical
Outcome Study- short form (SF- 36), Psychological General well-being Scale (PGWB),
Hospital Anxiety and Depression Scale (HADS) scores in patients with chronic pain
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compared to normal population which are indicative of major physical, social and
psychological impairments (Becker et al., 1997).People with chronic musculoskeletal pain
report worse health related quality of life in comparison to patients with end-stage cancer
(Fredheim et al., 2008). Researchers have shown that chronic pain can lead to depression
and other mood disorders, sleep disturbances, chronic fatigue syndrome and overall
decrease in physical and mental functioning (Ashburn & Staats, 2017;Phillips, 2009). A
survey conducted on 85,088 people from Europe, USA, Africa, Asia and the Middle East
found that people with a history of chronic neck or low back pain had 2.3 times higher odds
for mood disorder, 2.2 times more for anxiety disorders and 1.6 times more odds for
developing substance abuse disorder in comparison with people who did not endorse any
chronic pain symptoms (Demyttenaere et al., 2007). It is alarming that the rate of
committing suicide is much higher among chronic pain patients compared to the general
population. Suicide rates remain significantly higher even when mental disorders are
controlled (Lynch, 2011).
The problem of chronic pain is compounded by consistent findings that there are no
obvious findings on routine diagnostic imaging that can explain the pain symptoms. This
has led to experiences of stigma, scrutiny and alienation amongst many dealing with
chronic pain (Rhodes, McPhillips-Tangum, Markham, & Klenk, 1999).
Despite the high prevalence, there is by comparison relatively little guidance to support
treatment decisions available to clinicians. The mechanisms to explain the progression to
chronic pain after an acute musculoskeletal traumatic event also remain elusive. It is
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necessary to develop more integrated and explanatory pathways to predict and prevent the
development of chronic pain.

1.2 Available treatment resources of chronic pain
Proper diagnosis and management of chronic pain still remains ambiguous. Several
treatment options have been evaluated for the management of chronic pain including
pharmacotherapy (Rosenblum, Marsch, Herman, & Russell, 2008), psychological therapy
(Eccleston, Morley, & Williams, 2013) and physical therapy (Alami et al., 2011). However
no one approach alone proves to serve the best in terms of chronic pain management as the
development of chronic pain from acute trauma is not straightforward or well defined.
Available evidence on non-pharmacological approaches to chronic pain generally indicate
a small effect (Teasell et al., 2010a). Even many of the pharmacological agents provide
temporary relief of pain and small effects and there are controversies regarding the
effectiveness, safety and abuse liability of long term use of those agents (Rosenblum et al.,
2008;Chang & Compton, 2013). Despite some progress in creating opioids with lower
abuse potential, scientific and anecdotal evidence of fatal consequences from chronic
opioid use remain (Centre for Addiction and Mental Health Prescription opioid Policy
Framework -Canada, 2016).
Several reasons have been cited for the long term sufferings of people with chronic pain
such as poorly equipped pain clinics with long wait lists, under diagnosis of the problem
and lack of knowledge regarding the mechanisms to explain the development of chronic
pain (Lynch, 2011).
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The introduction of the biopsychosocial model in the management of chronic pain offered
several breakthrough clinical approaches (Gatchel, 2013). According to this model the
development of chronic pain is the result of complex interactions between biological,
psychological and environmental factors (Gatchel et al., 2013). This multidimensional,
well accepted model has suggested that managing chronic pain through biological or
psychological means in isolation was not sufficient to prevent the progression from acute
to chronic pain or to improve outcomes in chronic pain. Rather clinicians should focus on
the tailored approach based on individual's specific needs (Gatchel et al., 2014; Sessle,
2012). Although there have been some improvements in our understanding of the
mechanism of chronic pain, considerable gap in knowledge regarding clarifications of the
mechanisms, etiology, and pathogenesis of most chronic pain conditions still exist. While
the relationships between biological markers and acute self-reported psychological distress
was explored to some extent by prior research studies, the environmental and social
counterpart of this model received relatively less attention (Sessle,2012). One of the
motivations of this thesis is to achieve a deeper understanding of the rich interactions
between biological, psychological and social factors that will help to improve the current
treatment for acute, and by extension, chronic pain.

1.3 Prognostic factors in the development of chronic pain
following acute trauma
Recent efforts in the field of chronic pain research have endorsed an approach of early
identification and intervention in those people with acute pain that are likely to transition
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into a state of chronicity, attempting to prevent the onset of chronic pain. Numerous
psychosomatic investigations have dealt with the etiology and dynamics of chronic pain
syndromes. A growing body of literature has agreed that the development of chronic pain
involves complex and dynamic interactions of biological, psychological and environmental
factors (van Hecke, Torrance, & Smith, 2013; McLean, Clauw, Abelson, & Liberzon,
2005). However the exact mechanism that can explain the development of chronic pain
after an acute episode is not yet fully understood. A number of models or frameworks have
been developed to attempt to explain the reasons why a subset of people experience
persistent pain following an acute traumatic event while the majority of patients recover.
Different pain models explored several risk / prognostic factors that include biological,
cognitive and environmental elements (Walton & Elliott, 2017; Leeuw et al., 2007;
McLean et al., 2005). Currently the best available evidence indicates that the most
consistent predictors of chronic pain are largely cognitive in nature, including high ratings
of pain intensity or disability, fear, catastrophizing, and low expectations of recovery
(Walton et al., 2013a). However, recent large pragmatic clinical trials intended to
specifically target negative cognitions have found no added benefit over a single session
of advice and education or standard treatment (Lamb et al., 2012; Jull, Kenardy, Hendrikz,
Cohen, & Sterling, 2013). While it would seem that a propensity to rate the experience as
more terrible or distressing in the acute stage of injury is temporally associated with longer
term outcome, the results of these intervention trials would suggest the mechanisms to
explain these associations are not yet understood. It is worth exploring the knowledge gaps
regarding acute stress markers and to integrate biological, psychological and social markers
to identify major intervention targets.
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The following section will provide a detailed overview of the acute stress markers and their
potential roles in the progression from acute pain to chronic pain conditions.

1.4 Stress markers
This section provides an overview of the different biological, psychological and social
stress markers that have been proposed by previous researchers to explain the possible
mechanism of chronic pain development. The proposed role of those biomarkers in various
stress related maladies are also discussed. At first, a brief description of "stress" in general
is provided.

1.4.1

Stress

The term "Stress" was introduced by Selye (1936) as the body's nonspecific adaptive
response to any demand. He compared stress reaction with alarm process that warns us
about imbalance in homeostasis. According to McEwen (2003) a stressor is a real or
implied threat to homeostasis. Stressors can be pleasant or unpleasant; real or perceived;
physiological or psychological (H Selye, 1936; Selye, 1973; Russell et al., 2012). Selye
(1973) gave an example to clarify the idea of stress. When a mother realizes that her son
has some devastating disease, she experiences emotional stress that may require a shift in
what she considers ‘normal’ to cope with the perceived threat. If she finds later that the
diagnostic report was wrong and her son is completely fine that incident of extreme joy is
also considered as a stress in that it leads to another shift in homeostatic status to another
state of ‘normal’. In these two situations the stressors are completely different yet their
response could be exactly same. In order to re-establish the normal environment, our body
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produces several reactions. However, if the exposure to the stressors continues for a
prolonged period of time the stress response becomes maladaptive which has been
associated with various pathophysiology including chronic musculoskeletal pain (Louw,
Diener, Butler, & Puentedura, 2011; Poleshuck et al., 2009), Post traumatic stress disorder
(McFarlane, Atchison, & Yehuda, 1997), Fibromyalgia (Gupta & Silman, 2004), Diabetes
(Byung-Wan et al., 2010), Depression (Yehuda, Halligan, Golier, Grossman, & Bierer,
2004), Cardiovascular disease (Schwartz et al., 2015; Dimsdale, 2008) and poor pregnancy
outcome (Latendresse, 2009). The maladaptive stress pathway and its role in the experience
of acute pain will be explored in this research.

1.4.2

Biological stress markers

When the human body encounters a real or perceived threat to homeostasis it activates a
complex range of responses including endocrine, metabolic, nervous and immune systems.
Activation of the stress response ensures survival in the presence of adverse stimuli. One
common pathway is activation of the autonomic nervous system (ANS). It provides a rapid
response through both sympathetic and parasympathetic systems. Sympathetic system
response is referred to as the classic "fight, flight or freeze" response (Canon, 1929).
Neurotransmitters that are released by the neurons of ANS are epinephrine, norepinephrine
and acetylcholine (McCorry, 2007). Sympathetic adrenomedullary circuit, noradrenergic
neurons and parasympathetic system also have role in body's adaptation process (S. M.
Smith & Vale, 2006). These responses include some physical and psychological
phenomena such as increased blood flow to the muscle, increased cardiovascular tone,
increased blood pressure, increased blood sugar and fat deposition to order to supply the
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body with extra energy, the blood clotting system speeds up to prevent extra blood loss,
increased muscle tension to provide extra speed and strength, increased respiratory rate,
increased awareness, improved cognition and euphoria, decreased feeding and appetite
(Carrasco & Van De Kar, 2003; Smith & Vale, 2006; McCrory, De Brito, & Viding,
2010;Canon, 1929).
One of the objectives of this thesis was to explore the role of biological stress markers in
acute post-traumatic pain. Three stress biomarkers were specifically explored in my study,
namely cortisol, brain-derived neurotrophic factor (BDNF), and transforming growth
factor beta1 (TGFB1) owing to their recognized involvement in stress pathways. The
detailed descriptions of these three biomarkers are discussed in the following sections.

1.4.2.1

Cortisol

General description and mechanism of action:
Cortisol is a steroid hormone that is essential for maintaining homeostasis of the human
body. Removal of the adrenal gland from body can be fatal if glucocorticoid is not
administered externally (McEwen, 2006; McEwen & Wingfield, 2003).
The main three glands that play a vital role in the initiation of the stress response are the
paraventricular nucleus of the hypothalamus, the anterior lobe of the pituitary gland and
the adrenal gland. Collectively they are known as Hypothalamic- Pituitary -Adrenal (HPA)
axis. The HPA axis is the major stress system pathway in humans (Carrasco &Van De Kar,
2003; Hans Selye, 1973; Smith & Vale, 2006; Tsigos & Chrousos, 2002). Upon
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encountering a hostile environment or threat, the HPA neuroendocrine cascade initiates the
release of corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) in the
hypothalamus. Hypophysiotropic neurons of the paraventricular nucleus of the
hypothalamus synthesize and secrete CRH. CRH binds with the corticotrophin-releasing
hormone receptor-1 (CRHR1) and stimulates the anterior pituitary gland to release
adrenocorticotrophic hormone (ACTH) into the systemic circulation. ACTH binds with
the melanocortin type 2receptor (MC2-R) in the adrenal cortex and acts on the Zona
fasciculata. Zona fasciculata is the second of the three layers of the adrenal cortex, in order
they are Zona glomerulosa, Zona fasciculata and Zona reticularis. This binding action to
the mid layer of the adrenal gland triggers the synthesis and secretion of glucocorticoid
(cortisol in primates and corticosterone in rodents). Glucocorticoids play a prominent role
to regulate the magnitude and duration of HPA axis activation. Glucocorticoid acts on the
hypothalamus and pituitary to suppress CRH and ACTH production in a negative feedback
cycle, thus downregulating these hormones once the stressor has been eliminated (Tsigos
& Chrousos, 2002; Smith & Vale, 2006;Tasker & Herman, 2011; Rivier & Vale, 1983;
McEwen & Wingfield, 2003). This negative feedback loop is essential to ensure the return
of the HPA axis to homeostasis when the organism is no longer challenged (Canon, 1929).
Cortisol is a potent glucocorticoid hormone and a key biomarker of HPA axis which
received considerable attention in biomedical and clinical research. The HPA axis not only
promotes adaptation to stressors, but also leads to pathophysiology when it is dysregulated.
One of its many functions is to stimulate gluconeogenesis (production of glucose) in the
early hours of fasting. Cortisol also aids in the metabolism of fat, protein and carbohydrate.
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Cortisol prevents sodium loss from the cells and accelerates the rate of potassium excretion,
helping to regulate the body's PH balance. Cortisol also prevents the release of proinflammatory cytokines from macrophages, helper T-cells and related immune cells that
promote inflammation. While exposure to a stressor results in release of certain
inflammatory cytokines namely Tumor Necrosis Factor (TNF), IL-1b, and IL-6, HPA axis
activity and cortisol suppress the further release of these pro-cytokines (Tian, Hou, Li, &
Yuan, 2014). However, several studies reported higher level of pro-inflammatory
cytokines in chronic stressful conditions (Wolkow, Aisbett, Reynolds, Ferguson, & Main,
2015; Tian et al., 2014). It has been proposed that chronic stressful condition results in
glucocorticoid receptor resistance (GCR). GCR is responsible for up regulation of
inflammatory cytokines which can lead to serious health consequences (Cohen et al.,
2012).
The influence of stressful conditions on cortisol production and its proposed role in the
development of several pathological conditions including chronic pain:
The features of dysregulated HPA axis function includes fatigue, malaise, abnormal
metabolism, impaired sleep and the presence of widespread pain which are also the main
characteristics of several chronic pain disorders (Chrousos, 2004). This was one of the
main reasons for which cortisol received much attention in chronic pain research.
Animal studies have proposed the role of HPA axis dysfunction in the development of
chronic pain and inflammation. Persistent stress has been cited as the main reasons for the
HPA axis dysregulation in most animal studies (Tanriverdi, Karaca, Unluhizarci, &
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Kelestimur, 2007). For example, rats that were exposed to stressful conditions during
pregnancy via application of a stressor such as restraint or dexamethasone injection gave
birth to offspring with increased basal plasma corticosterone level (Blackburn-Munro,
2004). Maternal separation for 6 hours daily throughout the first 3 weeks of life resulted in
a hypercortisolism state in animal studies (Plotsky & Meaney, 1993; Blackburn-Munro,
2004). In human studies, the possible dysregulation of HPA axis after stressful events and
the development of pathological conditions continue to be examined. Although there are
sufficient evidence to support that cortisol is implicated in the pathophysiology of different
pain related disorders, research has yet to identify the exact mechanism involved in the
dysregulation of HPA axis (Chrousos & Kino, 2007).
Fibromyalgia is a common pain disorder which is characterized by chronic widespread
pain, fatigue, anxiety and poor sleep (Tanriverdi et al., 2007). The involvement of HPA
axis in the development of fibromyalgia has been increasingly documented by previous
research. However, there are inconsistencies regarding the exact role of HPA axis or
cortisol in this condition. There is evidence that in Fibromyalgia the concentration of
circulating cortisol is increased which reflects the HPA axis dysfunction (Bote, Garca,
Hinchado, & Ortega, 2012). However, Tanriverdi and colleagues found the opposite, a
reduced level of plasma cortisol in a cohort of people with fibromyalgia (Tanriverdi et al.,
2007) . The alteration of HPA axis function was also documented in conditions like chronic
pelvic pain. The associations between CPP and HPA axis dysfunction was found to be
mediated by chronic depression (Wingenfeld et al., 2009) suggesting a possibly complex
interaction between pain, mood, and stress activity that may explain the apparently
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opposing findings from the fibromyalgia literature. Increased plasma cortisol was also
observed in conditions like Chronic migraine and temporomandibular joint disorder (Peres
et al., 2001; Korszun et al., 2002). In contrast, lower cortisol concentration was observed
in chronic musculoskeletal pain, whiplash syndrome, chronic fatigue syndrome and posttraumatic stress disorder (Yehuda & Seckl, 2011; Gaab et al., 2005; Heim, Ehlert, Hanker,
& Hellhammer, 1998; Generaal et al., 2014). Park and Ahn found lower cortisol awakening
response (CAR) in patients with Complex regional pain syndrome who reported frequent
attacks of pain compared to patients who reported lower frequency of spontaneous pain
attacks (Park & Ahn, 2012).
From the above-mentioned discussion, it can be interpreted that the cortisol concentration
and HPA axis activity are highly variable in previous studies. The variability in the results
regarding cortisol and chronic pain may be due to the demographic differences of the
participants, the methods used for the study, the stage of the specific disease, the inclusion
of potential effect modifiers or interaction variables, and the interpretation of the results
(Tanriverdi et al., 2007).
Several researchers have anticipated the role of several demographic variables, early life
stress, recent stress and social disadvantages in the alterations of HPA axis function in at
least a subset of population (Essex et al., 2011; Dowd, Simanek, & Aiello, 2009). All these
factors should be evaluated while interpreting the role of cortisol in the development of
chronic pain. There is increasing evidence that childhood adversities (e.g. experience of
abuse, parental separation, household breakdown, loss of security) lead to persistent
changes in the HPA axis regulation (McGowan, 2013). However, the findings are
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inconsistent throughout the studies. Some studies suggested higher level of salivary and
hair cortisol concentration in people who reported childhood adversities (Schreier, Enlow,
Ritz, Gennings, & Wright, 2015). Rats who encountered parental separation showed
increased corticosterone production. There is also evidence of increased salivary cortisol
response in people who lost their parents in early age (Luecken, LJ &Appelhans, 2006).
In contrast, some studies found decreased salivary cortisol concentration in people with
history of adverse parenting and childhood maltreatment in compared to people who have
not reported such adversities (Kawai et al., 2017).
The alterations of HPA axis activity by several sociodemographic factors was also
investigated by recent research. Lower socioeconomic status, lower income, and education
level all have been cited as risk factors for the development of chronic pain conditions
(Oliver

van

Hecke,

Torrance,

&

Smith,

2013;

Udom,

Janwantanakul,

&

Kanlayanaphotporn, 2016). It has been proposed that the influence of these variables to the
development of chronic pain may be mediated by the dysregulation of HPA axis activity
(Ulirsch et al., 2015).
Although cortisol measures have contributed much to the literature; the role of the HPA
axis and cortisol following acute stressful event is still not well understood. To the best of
our knowledge, this is the first study which will explore the acute reactivity of plasma
cortisol level immediately after non-catastrophic musculoskeletal trauma. The modifying
effects of the demographic variables and childhood adverse experiences on the acute stress
response will also be explored to provide an insight about the mechanism of chronic pain
development following acute traumatic event.
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1.4.2.2

The brain-derived neurotrophic factor (BDNF)

General description and mechanism of action:
One of the most abundant neurotrophins of the mammalian central nervous system is
BDNF (Li et al., 2005). BDNF belongs to the family of Nerve growth Factor (NGF) which
promotes the survival and maintenance of brain function (Binder & Scharfman, 2004).
BDNF is considered an essential protein that acts on the neurons of the central and
peripheral nervous systems and helps in survival and growth of the existing neurons. It also
ensures growth and differentiation of the new neurons and synapses (Generaal et al., 2016;
Daskalakis, De Kloet, Yehuda, Malaspina, & Kranz, 2015). The role of BDNF is well
recognized in central nervous system development, maintenance and adult neuroplasticity
which is essential for wellbeing(Carbone & Handa, 2013; M. A. Smith, Makino,
Kvetnansky, & Post, 1995). BDNF protein is active at the connections between nerve cells
(synapses), where cell-to-cell connection occurs. The synapses can change themselves over
time in response to experience, which is known as synaptic plasticity. The BDNF protein
helps regulate synaptic plasticity. Synaptic plasticity is important to maintain learning and
memory. The brain-derived neurotrophic factor (BDNF) is one of the most studied
neurotrophins of the central nervous system in the development and maintenance of brain
function. BDNF plays an important role in neurogenesis, the process by which new neurons
are developed in the brain. Previous researchers showed that mice who were BDNF gene
deficient suffered developmental anomalies and also died soon after birth (Kucera, Lee,
Loring, & Jaenisch, 1995).
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BDNF is synthesized in the endoplasmic reticulum as a small precursor protein, pro BDNF.
Pro BDNF undergoes two cleavage steps to form mature BDNF, which remain stored in
secretary vesicles. Upon neuronal stimulation, BDNF is released from the synapse. It binds
with at least 2 receptors to exert its effects. One is a low affinity nerve growth factor
receptor (commonly known as p75) and the other one is a high-affinity protein kinase
receptor known as tropomyosin related kinase B (TrKB). The biological role of p75 is not
clear yet. Most of the effects to maintain neuronal integrity and survival mediated by BDNF
are thought to occur following binding to TrKB receptor (Carbone & Handa,
2013;Daskalakis et al., 2015; Kucera et al., 1995;Barrett, 2000).
The influence of stressful conditions on BDNF expression and its proposed role in the
development of several pathological conditions including chronic pain:
Brain derived neurotrophic factor disturbances and stressors have been shown to induce
different life long adverse health consequences both independently and in interactions.
Considerable evidence (mostly animal studies) suggest that both the early life stress and
recent stress has the potential to alter the BDNF expression and this can lead to various
hazardous health consequences (Daskalakis, De Kloet, Yehuda, Malaspina, & Kranz,
2015; Elzinga et al., 2011).
Although limited in numbers, studies have reported an association between BDNF
expression and the development of chronic pain related conditions in humans. However
the results of these studies are inconsistent. The precise mechanism underlying this
association has not been fully understood to date.
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It has been observed that the rats with a history of frequent maternal separation during
childhood displayed lower BDNF level (D. Liu, Diorio, Day, Francis, & Meaney, 2000).
This hypothesis was supported by similar findings in human studies later. Several studies
reported lower BDNF level associated with early and recent life stressors and lower BDNF
level has been implicated in the development of several negative health states such as
depression and bipolar disorder (Elzinga et al., 2011; Fernandes et al., 2015). It has been
proposed that altered BDNF expression along with environmental adversities may result in
the development of depressive disorders. As the pathophysiology of depression share many
similarities with chronic pain it was hypothesized that there may be a role for BDNF in
the development of chronic pain (Maletic, 2009). Moreover, BDNF appears to play an
important role in central sensitization (Generaal et al., 2016). Central sensitization is a
condition in which the nervous system goes through a wind up process and gets regulated
in a continuous state of high reactivity (Latremoliere & Woolf, 2010). Central sensitization
is thought to be associated with fibromyalgia, low back pain, whiplash headache and
osteoarthritis. The influential role of BDNF in the central sensitization makes it a novel
target to prevent chronic pain development (Nijs et al., 2015).
It is interesting to note that cortisol has emerged as an important mediator of BDNF
expression. Recent research has shown that stress induced increase in glucocorticoid level
leads to reduced BDNF in the hippocampus (Lakshminarasimhan & Chattarji, 2012).
According to recent research, high BDNF and low cortisol is essential for the neuronal
maintenance and synaptic integrity. This Glucorticoid - BDNF equilibrium should be
maintained throughout the life in order to properly regulate stress (Daskalakis et al., 2015).
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1.4.2.3

Transforming growth factor beta 1 (TGFB1)

General description and mechanism of action:
TGFB1 is a polypeptide that belongs to the cytokine family. Three isoforms exist in
mammals (TGF-beta 1, beta 2 and beta 3). Among them, TGFB1 has widely been regarded
as an injury related cytokine. It performs many cellular functions, including cell growth,
cell proliferation, cell differentiation and apoptosis. It also plays an important role in the
immune system of our body (Gomes, Sousa, & Romão, 2005). In humans it is encoded by
TGFB1 gene. Most of the immune cells or leukocytes secrete TGFB1 and most of the cells
have receptors for TGFB1. Hence, it is likely that this growth factor must be properly
regulated to maintain homeostasis and prevent disease (Khalil, 1999). TGFB1 is produced
in cells such as platelets, macrophages, B-lymphocytes and T-lymphocytes, fibroblasts,
osteoblasts and osteoclasts, astrocytes, and microglial cells. The mechanism of regulation
of TGFB1 is complex. TGF beta is produced in a latent form that must be activated to
produce its biologically active form (Khalil, 1999) .
The variation in TGFB1 expression and its proposed role in the development of several
pathological conditions including chronic pain:
Increase or decrease of TGFB1 level has been found to be associated with the development
of several chronic conditions such as chronic obstructive pulmonary disease, Rheumatoid
arthritis, Systemic lupus erythematosus, Osteoarthritis, chronic kidney disease and
atherosclerosis (Celedón et al., 2004; Shen, Li, & Chen, 2014; Blobe,Schiemann,& Lodish,
2000). To date, no studies have evaluated TGFB1 in the development of chronic
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musculoskeletal pain. Although very limited in number, few studies have suggested the
potential role of TGFB1 in normal nociceptive pain processing as well as in the
development of pathological pain conditions. TGFB1 has got some important
neuroprotective effects. It has the capability to minimize the damage to the neurons
following peripheral nerve injury (Echeverry et al., 2009; Lantero, Tramullas, Díaz, &
Hurlé, 2012). It reduces pro-inflammatory cytokines induced nerve lesion. All these actions
are helpful to prevent the development of neuropathic pain (Echeverry et al., 2009).
Therefore, TGFB1 was hypothesized to have some potential role as an intervention target
in pain management (Lantero et al., 2012).
Mice deficient of TGFB1 showed increased neuronal cell death whereas over expression
of TGFB1 protects against neurodegeneration in acute and chronic injury paradigm
(Brionne, Tesseur, Masliah, & Wyss-Coray, 2003). This result is in line with some human
studies that found the up regulation of TGFB1 following cerebral ischemia to prevent
further neurodegeneration (Dhandapani & Brann, 2003). It has been suggested to play an
important role to reduce the damage induced by a wide range of insulting agents including
hypoxia, ischemia, oxidative damage etc. (Dhandapani & Brann, 2003). Therefore TGFB1
can be an attractive candidate to explore in the acute traumatic condition to get an idea
about the preventive strategies of TGFB1 against chronic pain development following
acute trauma.
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1.4.3

Psychological variants of stress markers

The ability of psychological factors to facilitate the development of chronic pain is well
established by resent research. The acceptance of psychological factors and their
correlations to the onset and outcomes of acute pain episodes is increasing. Variables such
as attitudes, perceptions, mood state, social factors and work appear to interact with pain
behavior and are collectively called psychosocial factors. It is necessary to explore these
psychological variables and their associations with other stress markers to understand the
cognitive, emotional, and behavioral manifestations of pain.
Existing evidence suggest that the most consistent psychological predictors of chronic pain
development are pain catastrophizing and self-reported psychological distress (Walton et
al., 2013a; McLean et al., 2005; Quartana et al., 2010). Most of the current research has
agreed that there is a significant relationship between excessive fear of pain or pain
catastrophizing following acute trauma and the development of chronic pain and disability.
Pain catastrophizing is defined as the tendency to magnify or exaggerate the threat or
seriousness of pain sensation (Chaves & Brown, 1987). People who catastrophize become
so overwhelmed with pain related fear or worry that they cannot distract their attention
from pain. The overall literature suggests that exaggerated psychological responses to acute
pain are maladaptive and likely to intensify the pain experience and delay recovery. High
level of catastrophizing after acute trauma should be considered a risk factor for chronic
pain development (Quartana et al., 2009; Innes, 2005). These associations can be
understood through the fear avoidance model of chronic pain. The fear avoidance model
of chronic pain is one of the most influential models of chronic pain development. The fear
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avoidance model described the role of excessive fear of pain or catastrophizing and
avoidance behavior in the progression from acute to chronic pain related conditions. In the
acute phase of trauma, avoidance of some activities may be beneficial. However, prolonged
avoidance of activities due to catastrophic beliefs about the pain outcome and fear of re
injury may lead to chronicity, disuse and disability (Vlaeyen & Linton, 2012).
Self-reported psychological distress following acute trauma was also cited as a prognostic
factor for the development of chronic pain conditions (Walton et al., 2013a). It has been
reported that as many as one third of people after having a traumatic event experience some
forms of psychological distress (Innes, 2005). Despite a growing body of literature
suggesting the role of psychological factors in the development of chronic pain, these
factors are not completely understood and evaluated following acute traumatic events. The
association of dysregulated HPA axis function in the development of psychological distress
and pain catastrophizing was supported by recent research(Walton, Macdermid, Russell,
Koren, & Uum, 2013). Inclusion of psychological and physiological stress markers is a
unique aspect of my research study.

1.4.4

The influence of social stress markers (early life adversities)
on the development of chronic pain conditions

Research studies have predominantly focused on the effects of adverse childhood
experiences as it has emerged as an important indicator of adult health and wellbeing (De
Bellis & Zisk, 2014; Vincent J Felitti & Anda, 2010). According to WHO World Mental
Health Survey, physical abuse, sexual abuse and exposure to family violence was reported
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by 5- 11%, 1-2% and 4-8% respondents, respectively, of people surveyed from 21
countries (Kessler et al., 2010). Patients with chronic widespread pain are more likely to
report adverse childhood experiences than those who do not report such adversities
(Davis&Luecken, 2005). In North America there is increasing evidence that abused women
report more pelvic pain, multiple somatic symptoms and more lifetime surgeries compared
to non-abused women (DA, Leserman, Nachman, & Al, 1990).
Previous researchers often mentioned the history of childhood adversities as a potential
venue to look for to understand the development of chronic pain related conditions (Lampe
et al., 2017; Linton, Lardén, & Gillow, 1996). Sexual abuse history has been found to be
associated with chronic musculoskeletal pain (Linton et al., 1996). It was suggested that
people with sexual abuse history may have diminished ability to cope with the pain. As a
result, they reported higher level of distress and that may contribute to the persistence of
pain (Linton et al., 1996). Several studies have reported the associations of childhood
physical, sexual and emotional abuse and the development of fibromyalgia in adulthood
(Häuser, Kosseva, Üceyler, Klose, & Sommer, 2011; Walker et al., 1997). Similar patterns
of associations were reported between abuse and post-traumatic stress disorder (Lang et
al., 2008). Elevated rates of childhood trauma were also reported by a sample of patients
with chronic low back pain (Linton, 1997). It has been suggested that the individuals who
report childhood physical or sexual abuse are 4 to 5 times more likely to have chronic pain
problems in adulthood (Linton, 1997). The high frequency of childhood abusive history
among people with chronic pain conditions make it a potential candidate to include in the
routine assessment of chronic pain related disorders (Linton et al., 1996). As with most
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such relationships, the evidence is not consistent and may be confounded by recall bias.
There is evidence that childhood sexual abuse did not have any role in the development of
chronic pain (Lampe et al., 2017). Raphael et al. (2001) documented no associations
between childhood abuse and pain in adulthood when childhood abuse history was
determined by court documented cases. Interestingly, they found positive associations
between abuse history and chronic pain when they used self-reported retrospective data to
evaluate the abuse history (Raphael, Widom, & Lange, 2001). It has also been proposed
that childhood victimization is associated only with pain of psychogenic origin rather than
pain of clear organic origin (Adler, Zlot, Hürny, & Minder, 1989).
It is clear from the above discussion that the results regarding the influence of childhood
adversities on chronic pain development in adulthood are variable throughout the literature.
Moreover, most of the studies focused on specific types of abuse (either physical or sexual)
to explore its role in the development of chronic pain. The current thesis will explore the
modifying role of childhood adversities (physical, sexual and emotional abuse, neglect,
household dysfunction) on the acute stress markers.
The existing literature regarding the relationship between childhood victimization and
stress system regulation remain inconclusive. There is increasing evidence that childhood
adversities lead to persistent changes in the HPA axis regulation via epigenetic mechanism
(McGowan, 2013). Epigenetics refers to the reversible regulation of various genomic
functions without changing the underlying DNA sequence. Rodent models have provided
support to the idea that early life stress contribute to chronic disorders via epigenetic
mechanisms (Moffitt & Tan, 2013). Though the idea of epigenetic plasticity is in its infancy
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in human studies, it has been proposed that the history of childhood abuse could cause
permanent stress system dysregulation which makes the abused population more
vulnerable to stressors and more likely to develop chronic pain following acute trauma
(Heim, Plotsky, & Nemeroff, 2004; McLean et al., 2005).
Besides cortisol and HPA axis, some other biomarkers such as BDNF and TGFB1 have
expressed themselves as potential avenue via which early life stress may influence the
development of chronic pain conditions. A recent rodent study found epigenetic changes
in BDNF expression in rats that experience childhood maltreatment. The study observed
that the rats that were exposed to maltreatment by stressed caretakers showed methylation
of BDNF DNA and which resulted in reduced BDNF gene expression in the prefrontal
cortex. They also reported altered BDNF DNA methylation in the offspring of those
maltreated females. Interestingly, their offspring had not been exposed to any childhood
adversities. This may indicate the transmission of altered genes throughout generations
(Roth, T.L., Lubin, F.D., Funk, A. J., Sweatt, 2009). In another animal study, two groups
of primates were reared in two different conditions were examined. The group that was
exposed to adversities in early life showed no significant correlation with cortisol following
stressful condition in adulthood. On the other hand, the group reared in normal environment
showed strong correlation with cortisol (Smith, Batuman, Trost, Coplan, & Rosenblum,
2002).
From this narrative overview of stress biomarkers, psychological markers, and early life
adversity it can be concluded that there are several outstanding questions about the
mechanisms underlying stress, the involvement of childhood adversities and the experience
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of acute or chronic pain. I believe that the conflicting findings from some previous stress
biomarker work may be due to the lack of control for potentially important social and early
life experiences in the subjects. Also, most such work has been conducted in animals with
relatively little done in humans under natural conditions. However, the promising results
of these animal studies indicate that they are worthy to explore in human studies too. As a
preliminary step to unfold the mechanism by which abuse affects chronic pain, the current
study will explore the associations between pain, psychological distress, physiological
biomarkers, and early life adversities in a sample of people following acute
musculoskeletal trauma.

27

Chapter 2

2

Methodology

2.1 Introduction
Chronic musculoskeletal pain has been described as a "silent epidemic" of the modern,
civilized world (Sessle, 2012). It is the most common cause of severe long term physical
disability and is frequently accompanied by psychological co-morbidities such as
depression, distress or anxiety (Bair, Robinson, Katon, & Kroenke, 2003). Chronic pain
affects millions of people around the world. It has been estimated that one of every five
North American adults has chronic pain at any one time (Moulin et al., 2002)and pain
accounts for 80% of all physician visits (Gatchel, Robert J.; Peng, Yuan Bo; Peters,
Madelon L.; Fuchs, Perry N.; Turk, 2007).
Several studies have shown that chronic musculoskeletal pain results in significant
personal, economic, and social burdens. The estimated cost for chronic pain in Canada is
$1462 per patient per month and in North America is $635 billion per year (Gaskin &
Richard, 2012; Guerriere et al., 2010).The impact of chronic pain should not be evaluated
in economic terms solely. Chronic musculoskeletal pain patients report worse health
related quality of life in comparison to palliative cancer patients (Fredheim et al., 2008).
Despite the high prevalence, there is by comparison relatively little guidance to support
treatment decisions available to clinicians. Current guidelines endorse the use of
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polypharmacy in addition to non-pharmacological management including physical
therapy, stress management strategies, and psychological interventions, but what evidence
exists to support such approaches generally indicates a small effect (Teasell et al., 2010).
Recent efforts in the field have endorsed an approach of early identification and
intervention in those people with acute pain that are likely to transition into a state of
chronicity, attempting to prevent the onset of chronic pain before it emerges and becomes
resistant to treatment. The incidence of chronic problems following musculoskeletal injury
has been reported to range from approximately 20 to 50% depending on the conditions
(Kongsted, Kent, Hestbaek, & Vach, 2017; Rosenbloom et al., 2016). For example, current
best estimates following acute traumatic neck pain indicate that about 50% will continue
to report persistent problems 1 year later, and about 30% will report severe pain and/or
disability (Carroll et al., 2009; Sterling, 2011). Identifying mechanisms that can explain
the development of chronic pain has therefore been identified as a high priority research
area by experts in the field (Walton et al., 2016).The natural progression of mechanistic
research should then be the identification of therapeutic approaches to prevent the onset of
chronic pain.
Development of chronic pain is a complex interplay involving biological, psychological
and social factors (McLean et al., 2005). Currently the best available evidence indicates
that the most consistent predictors of chronic pain are largely cognitive in nature, including
high ratings of pain intensity or disability, fear, catastrophizing, and low expectations of
recovery (Walton et al., 2013a). However, recent large pragmatic clinical trials intended to
specifically target negative cognitions have found no added benefit over a single session
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of advice and education or standard treatment (Lamb et al., 2012; Jull, Kenardy, Hendrikz,
Cohen, & Sterling, 2013). While it would seem that a propensity to rate the experience as
more terrible or distressing in the acute stage of injury is temporally associated with poorer
outcome, the results of these intervention trials would suggest the mechanisms to explain
these associations are not yet understood.
Several stress biomarkers namely cortisol, Brain-derived neurotrophic factor (BDNF) and
Transforming growth factor beta 1(TGFB1) received attention in recent biomedical and
clinical research as having potential roles in the development of chronic pain. Cortisol is a
steroid hormone. It is considered as the major stress hormone of the human body. It is
produced in humans by the zona fasciculata of the adrenal cortex within the adrenal gland.
It is released in response to any kind of stressful situation (Smith & Vale, 2006). A growing
body of literature have supported the hypothesis that the stress system ( HPA axis )
dysfunction is associated with the pathogenesis of chronic pain following acute trauma
(Chrousos & Kino, 2007).BDNF is a member of the neurotrophin family of the growth
factor. Neurotrophic factors are found in the brain and the periphery(Lee & Kim, 2010).
BDNF is an important protein that acts on the neurons of the central and peripheral nervous
systems and helps in growth, differentiation and survival of the neurons (Generaal et al.,
2016). BDNF has been demonstrated as a novel therapeutic target in the treatment of
chronic pain due to its potential role in neuroplasticity and central sensitization (Nijs et al.,
2015). TGFB1 (Transforming growth factor beta 1) is a polypeptide that belongs to the
cytokine family. It performs many cellular functions, including cell growth, cell
proliferation, cell differentiation and apoptosis. It also plays an important role in the
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immune system. Most immune cells or leukocytes secrete TGFB1 (Khalil,
1999).TGFB1has shown to be involved in nociceptive pain processing. Hence, it was
hypothesized to have some potential role as an intervention target in pain management
(Lantero et al., 2012). However, the exact role of cortisol, BDNF and TGFB1 in the
development of chronic musculoskeletal pain following acute trauma continues to be
examined. We believe that deeper understanding of the rich interactions between
biological, psychological and social factors will help to improve the current treatment for
acute, and by extension, chronic pain.
Adverse childhood experiences (e.g. experiencing or witnessing abuse, early
parentification, poverty, parental incarceration or separation) appear to be more commonly
reported among patients with chronic health conditions and may function as an important
moderator of the association between negative affect, stress, and recovery from subsequent
musculoskeletal trauma in adulthood. Davis and Luecken found that people who reported
abusive childhood experiences are more likely to develop chronic pain conditions in their
adulthood (Davis & Luecken, 2005). Early childhood adversity has been endorsed as a
potentially valuable avenue for exploration in the search for mechanisms to explain the
development of chronic conditions such as musculoskeletal pain (Linton et al., 1996),
Posttraumatic stress disorder (Lang et al., 2008) , Fibromyalgia (Häuser et al., 2011),
Chronic pelvic pain (Hu, Link, McNaughton-Collins, Barry, & McKinlay, 2007), and low
back pain (Linton, 1997). Linton (1997) found that those who reported childhood physical
or sexual abuse were 4 to 5 times more likely to have chronic pain problems in adulthood
(Linton, 1997). However, as with the association between negative cognitions and chronic
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pain, the mechanisms to explain the link between adverse childhood events and the genesis
of chronic pain remain unclear. Work from the lab of Walton and others has recently found
that stress biomarkers (e.g. cortisol) appear to show associations with both negative
posttraumatic cognitions and acute pain intensity, and may function to influence the course
of recovery following trauma. To the best of our knowledge, the moderating effect of
childhood adversities on the associations between these biological and psychological stress
markers following acute trauma has yet to be explored.

2.2 Purpose
The main objectives of the study were to:
1) Explore differences in key stress biomarkers and self-rated pain intensity in a sample of
people with acute musculoskeletal injuries when grouped by age, sex, body mass index
(BMI), income level, education and medication history.
2) Explore the associations between major stress biomarkers (cortisol, brain-derived
neurotrophic factor (BDNF) and transforming growth factor beta1 (TGFB1)) and pain
severity and distress in the acute setting of pain.
3) Identify potential moderating effects of adverse childhood experiences on the
associations between stress biomarkers and pain-related cognitions.
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2.3 Methods and Materials
2.3.1

Study Design

This was a cross-sectional exploratory study.

2.3.2

Participants

Eligible participants were those who had experienced an acute, non-catastrophic
musculoskeletal injury within 1 week of presenting to the urgent care centre at St. Joseph’s
hospital (London Ontario, Canada). Participants were initially approached by their primary
clinician (either physician or emergency care nurse) who obtained consent to be contacted
by the research assistant for more information, full eligibility screening, and to obtain
informed consent if they were willing and eligible to participate. Participants received 30
Canadian dollars as compensation for their participation in this part of the study. Full
inclusion criteria were: aged 18 years or older, able to speak and understand English, and
presented for an acute injury affecting the musculoskeletal system that did not require
surgery or hospitalization. Exclusion criteria included those with cognitive impairments
that interfered with ability to follow detailed instructions, those with neuromuscular
disorders that impaired mobility (e.g. stroke, multiple sclerosis), any active malignancies
within the past 5 years, and active systemic inflammatory or autoimmune conditions (e.g.
rheumatoid arthritis, systemic lupus erythematosus). Finally, those who had been
diagnosed with a concussion or were hospitalized overnight at any point in the prior 6
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months, those under the influence of drugs or alcohol at the time of presentation to the
department, or those with no fixed address were excluded from this part of the study.

2.3.3

Procedure (sample and data collection)

After obtaining consent, participants were provided an intake and screening form and brief
questionnaire to gather more information at the time of presentation. Questions such as
"Are you pregnant or lactating" or "Are you taking any antibiotics currently" were
highlighted in the intake and screening form. The above mentioned two criteria are not
exclusion criteria for the study. However it is helpful to know about these kinds of
additional information to better understand the sample characteristics. Among all
participants, single patient was pregnant. As none of the stress biomarkers were out of the
normal reference range for that participant, they were retained for this study. Additional
metadata were collected at that time (e.g. age, sex, current medication use, and
pregnancy/post-partum status if applicable). Two vials of antecubital blood were then
collected by a trained phlebotomist that were immediately stored in a clinic freezer before
being transported to a laboratory for centrifugation and storage at -80C until extracted for
assay.
Participants were discharged from the department with a set of questionnaires for capture
of more detailed experiences after the traumatic event. These questionnaires captured a
number of constructs including additional metadata (height, weight, income, working
status, educational status, compensation/litigation involvement), Injury specifics
(mechanism, area injured, time since onset), and a series of standardized questionnaires

34

(described below). Participants were asked to complete the forms within 24 hours of
discharge.

2.3.4
2.3.4.1

Predictor (Independent) variables
Demographic factors

Age, sex, BMI, education, income, medication usage all these factors are used as
independent variables to test the hypothesis of this study.

2.3.4.2

The traumatic injuries distress scale (TIDS)

The Traumatic Injuries Distress Scale (Walton, Krebs, et al., 2016) is a 12-item
questionnaire designed to measure 3 different areas of trauma-related distress (negative
affect, uncontrolled pain, and intrusion/hyper arousal) following acute musculoskeletal
injuries. The TIDS is intended to capture affective vulnerabilities of the participants
following acute trauma. The scale is available in 3 languages: English, French and Spanish.
Walton and colleagues have found elevated scores on the TIDS to be associated with
slower recovery 3 or 6 months later (Walton, Krebs, et al., 2016).

2.3.4.3

The adverse childhood experiences questionnaire (ACE)

The Adverse Childhood Experiences (ACE) questionnaire is a 10-item self-report tool that
asks respondents to recall adverse events experienced in the first 18 years of life. High level
of childhood adversities were found to be associated with a 4 to 12-fold increased risk of
alcoholism, drug abuse, depression and suicidal attempt; a 2 to 4-fold increased risk of
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smoking and poor health habits; and a 1.4 to 1.6-fold increased risk of severe obesity
(Felitti et al., 1998). This is one of the widely used instruments to explore the cumulative
stress experienced during childhood. It has been used in pediatrics, mental health and other
health settings (Murphy et al., 2014).
ACE can provide retrospective reports about childhood abuse (physical, sexual and
emotional), neglect and household dysfunctions. Each question is rated dichotomously: yes
/ no. The ACE questionnaire has been shown to be adequately reliable and valid to identify
potentially vulnerable individuals with childhood adversities (Murphy et al., 2014; Felitti
et al., 1998). In the current study, the ACE questionnaire was used to divide the data into
two groups (one group who have endorsed at least one variety of childhood abuse and the
other group who have not endorsed any of them). The differences between these two groups
in the interplay between stress markers in the acute pain setting were explored.

2.3.4.4

The acute stress disorder scale (ASDS)

The ASDS scale (Bryant, Moulds, & Guthrie, 2000) is a 19-item screening tool intended
to screen for Acute Stress Disorder (ASD) using criteria defined in the Diagnostic and
Statistical Manual of Mental Disorder (DSM-IV; 4thed; American Psychiatric Association,
1994). The term "acute stress disorder" refers to the stress reaction that occurs within the
first month after having a traumatic event. People with acute stress disorder are more likely
to develop post traumatic stress disorder later in life (Edmondson, Mills, & Park,
2010;Harvey & Bryant, 2002). It is the most widely used self- report questionnaire to
diagnose "acute stress disorder" (Edmondson et al., 2010).
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The scale comprises 5 dissociative, 4 re-experiencing, 4 avoidance and 6 arousal
symptoms. The items are scored on a 5 point scale (1= not at all, 2=mildly, 3=medium, 4=
quite a bit, 5= very much). The total ASDS is scored by summing the scores of all the
items. The total ASDS score correctly identified 91% of people who developed subsequent
PTSD (Bryant et al., 2000). Despite of having high specificity in diagnosing PTSD, it has
showed lack of sensitivity in PTSD diagnosis (Bryant et al., 2000; Harvey & Bryant,
2002).

2.3.4.5

The brief pain inventory (BPI) - short form

The brief pain inventory (C S cleeland, 1994) is a self-administered questionnaire that was
initially developed to measure pain in cancer patients (C S cleeland, 1994). However, it is
also commonly used as an adequately valid and reliable measure of severity and
interference from non-cancer pain (Tan, Jensen, Thornby, & Shanti, 2004;Keller et al.,
2004). The BPI scale is easy to administer, available in many languages and easily
accessible (Tan et al., 2004). The BPI is very efficient in evaluating and identifying pain
intensity and associated disabilities in patients reporting lower back pain and arthritis
(Keller et al., 2004) and chronic non-malignant pain (Tan et al., 2004). It provides a quick
means of measuring pain intensity and the degree to which pain interferes with living and
general activities.
This 11-item self-report tool includes 4 items capturing pain intensity and other 7 items
reporting pain interference. The pain intensity subscale asks about worst pain, best (least)
pain, and average pain over a period of about 24 hours and current level of pain to measure
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the severity of pain. Each of the items is graded from no pain (0) to extreme pain (10) for
a scale range of 0 to 40. The 7 items pain interference subscale assesses how pain interferes
with activities of daily living such as general activity, mood, walking ability, work, relation
with other people, sleep and enjoyment of life. These 7 items are anchored with "does not
interfere" to "completely interferes" for a range from 0 to 70. Pain interference subscale
should be interpreted as 2 different domains -Physical interference and affective
interference. The item demonstrating sleep interference should be interpreted separately
(Walton, Beattie, Putos, & MacDermid, 2016). Current study used this scale to explore the
pain intensity and pain interference scores of people who underwent a traumatic
musculoskeletal injury.

2.3.5
2.3.5.1

Outcome (Dependent) variables
Cortisol

Assay technique:
Human plasma concentrations of cortisol were determined by radio immunoassay with a
commercially available kit (DetectX Cortisol Immunoassay kit; Arbor Assays, Michigan,
USA). Total cortisol was quantified according to the manufacturer's protocol. The assay
sensitivity was ascertained at 1.73pg/mL and the limit of detection was determined as
45.4pg/mL. The concentration of cortisol was calculated using software available with
most plate readers.
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2.3.5.2

BDNF & TGFB1

Assay technique:
Levels of brain-derived neurotropic factor (BDNF) and transforming growth factor beta 1
(TGFB1) were measured using multiplexed biomarker immunoassay kits according to
manufacturers’ instruction (BDNF: Human Magnetic Luminex Assay, R&D Systems, Inc.,
Minneapolis, USA, TGFB1: Milliplex MAP TGFB1 Magnetic Bead Single Plex Kit, EMD
Millipore Corporation, Missouri, USA). A Bio-PlexTM 200 readout System was used (BioRad Laboratories, Hercules, CA), which utilizes Luminex® xMAPTM fluorescent beadbased technology (Luminex Corp., Austin, TX). Levels were automatically calculated from
standard curves using Bio-Plex Manager software (v.4.1.1, Bio-Rad). Plasma BDNF and
TGBF1 protein levels were expressed in picograms per millilitre (pg/mL).

2.4 Data analysis
All variables were examined for missing values, outliers, normality of distribution, and
homogeneity of variance. At first, subject characteristics (age, sex, BMI, Income,
education) were evaluated descriptively (mean/ median, SD, range, frequency).
Independent variables were demographic factors, baseline ASDS (total score, distress
subscale, dissociation subscale), BPI (pain intensity subscale, pain interference subscale,
physical interference subscale, affective interference subscale, sleep interference subscale),
TIDS (total score, uncontrolled pain, negative affect and hyper arousal subscales) and ACE
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(those with/without at least 1 adverse experience endorses). The dependent variables on
the hypothesis being tested included stress biomarkers (Cortisol, BDNF and TGFB1).

2.4.1

Handling missing values and outliers

Where data were missing, we excluded the participant just for that analysis. Box plots and
scatter plots were generated to identify outliers. As correlations can be influenced by
extreme data, outliers (those that were more than 3 times the interquartile range) were
removed from this exploratory analysis. Data were removed cautiously at this preliminary
stage of research as outliers may indicate an interesting but rare subset of people. The rich
dataset including metadata offered ample opportunity to scrutinize each outlying data point
by exploring other characteristics of that participant. If that person showed proportionate
and consistent values in other related variables that were theoretically understandable then
that outlier was kept in the data set.

2.4.2

Data Normality

Shapiro-Wilk’s normality test was performed and a histogram was plotted to check the
normality of each variable. Stress biomarker variables were positively skewed initially. To
ensure the normality of the data square root transformation of variables were performed.
All the dependent variables were approximately normally distributed (according to the
Shapiro-Wilk test) after doing the square root transformation. Assumptions of normality
were not violated for most of the variables as all the p values were more than 0.05. Normal
Q-Q plot also indicated the normality of the data. However due to nature of the data and
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limited sample size normality could not be assumed for few self-reported variables. To
ensure the robustness of the results, non-parametric tests were performed in those variables.

2.4.3

Test for homogeneity of variance

Equality of variance was evaluated using Levene’s test. Where it was violated, a correction
factor was applied to avoid alpha error.

2.4.4
2.4.4.1

Data coding
Age

Age was provided in years. Median age (40 years) was used as the cut-off point.
Participants were divided into two groups according to their age; 40 or under (group =1)
and above 40 (group =2).

2.4.4.2

Sex

About 25 males and 46 females completed the study. Sex was coded as: male= 1, female=2.

2.4.4.3

BMI

Median value (26.1) was used as the cut off point for BMI. BMI was coded as 2 groups:
26.1 kg/m2 or under (group= 1), above 26.1 kg/m2 (group=2).
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2.4.4.4

Medication usage

There were 27 people who were taking anti-anxiety / anti-depressant medications at the
time of injury and 49 people who did not provide such history. Medication history was
coded as: not taking any anti-anxiety / anti-depression medications =0, taking anti-anxiety/
anti depression medications=1. These classes of drugs were considered the most relevant
considering the primary evaluations related to post-traumatic stress and affective
interference.

2.4.4.5

Income

There were 8 ranges provided in the questionnaire: < $ 20,000= 1; $20000-$40000= 2; $
41000- $60000= 3; $ 61000- $ 80000= 4; $ 81000- $100000= 5; $101000-$150000= 6;
$151000- $200000= 7; >$200000= 8. Income history was coded as ≤ CDN $100,000 total
household per year (group= 1) and income > 100,000 total household per year (group=2).

2.4.4.6

Education level

There were 7 levels in the questionnaire: did not finish school, high school, community
college, trade school, university undergraduate degree, master's degree, and doctorate.
Education was coded as Low education (group 1) = Trade school, community college, or
no post-secondary education and High education (group 2) = university undergraduate
degree or higher.
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2.4.4.7

Adverse childhood experiences

ACE questionnaire was used to determine the presence or absence of childhood adverse
history. Total 52 people endorsed at least one component of ACE questionnaire and 22
people indicated that they did not have such adversities in their childhood. These two
groups were coded as 1 (who had adverse childhood history) and 0 (who did not have such
histories) respectively.

2.4.5

Statistical tests (Hypothesis testing)

2.4.5.1

Hypothesis 1

There will be a significant difference in stress markers in the acute pain setting when the
sample is split according to age, sex, BMI, education level, income level, medication usage,
and adverse childhood experiences.
Stress level was determined according to the plasma level of stress biomarkers (cortisol,
BDNF, TGFB1) and also the self-report measures of stress following musculoskeletal
traumatic event. At first the sample is split into two groups according to age, sex, BMI,
education level, income level, medication usage, and adverse childhood experiences. Then,
Independent samples t-test was performed to explore differences between each group. As
some of the self-report questionnaires were not normally distributed Mann- Whitney Utest was used.
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2.4.5.2

Hypothesis 2

There will be significant correlations between biological and psychological markers of
stress following acute traumatic events.
Pearson's correlation coefficient (r) and Spearman's Rho (rho) were used to explore the
correlations between biological (cortisol, BDNF, TGFB1) and psychological (TIDS,
ASDS, BPI) stress markers in the acute pain setting. Then, multiple regressions were
performed to find out the proportion of variance of dependent variables that could be
explained by independent variables after controlling for any relevant confounding
demographics identified from hypothesis1. Preliminary analyses were performed to ensure
that there was no violation of assumptions of regression (normality, linearity,
multicollinearity and homoscedasticity).

2.4.5.3

Hypothesis 3

The history of adverse childhood experiences will moderate the correlations between acute
stress biomarkers and self-reported distress.
To test the hypothesis about the moderating effects of adverse childhood experiences, the
correlations between acute stress markers were generated when the sample is split in two
groups according to the scores of the ACE questionnaire. Significant correlations between
variables were plotted by scatter plots to visualize and compare the associations between
ACE and No ACE groups. All statistical tests were 2-tailed tests conducted at p ≤ 0.05,
unless otherwise indicated.
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2.4.6

Bootstrap resampling

A bootstrap resampling method was used to identify the 95% confidence interval of each
of the significant correlations. A sample size of 1000 was used to test the hypothesis. Those
correlation point estimates (Pearson’s r) that differed between ACE groups to an extent
that the point estimate of one was outside the 95%CI of the other were considered
significantly different associations.

2.4.7

Sample size estimation

Sample size was estimated assuming a medium effect size (Pearson’s correlations of 0.3 to
0.5) for our primary analyses, with a desired power of 80% to observe the effect while
accepting a 5% alpha error rate. G*power software version 3 was used for the calculation
(Faul, Erdfelder, Lang, & Buchner, 2007). As a result, a sample size of 84 subjects was
targeted.
Raw data from the ongoing study were analyzed using SPSS software version 23 (IBM
corp., USA).
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Chapter 3

3

Results and Discussions

3.1 Results
3.1.1

Sample characteristics

Within our recruitment timeline, 76 participants completed the study. A total of 691
patients were approached to participate of which 518 refused or were unable to comply
with the requirements of the study. Of the remaining173 who consented in the urgent care
department and provided blood, saliva and partial baseline data, 76 completed and returned
all baseline data and formed the sample for this study. The breakdown of total participation
is given below:
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Table 3.1 provides the participant characteristics. The sample was primarily female
(64.8%) of median 40 years of age. Modal education level was university undergraduate
degree (28%) and 60% were employed full time. There was a bimodal distribution of
income, where both $41,000 - 60,000 and $101,000-150,000 salary range were reported by
24.3% of the sample. The most common etiologies were fall on level ground and being hit
by an object (15.1% each). The modal body regions injured were ankle (25%), knee
(13.2%) and wrist (13.2%).
Table 3.2 provides details from the self-report tools and descriptive statistics of the stress
biomarkers (cortisol, BDNF, TGFB1). Some of the self-report data and plasma biomarkers
were not normally distributed. Hence, median and range are reported for them in table 3.2.
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Table 3.1: Demographic data of participants.
Characteristics
Age ( median, range )
Sex (no. female %)
Height in meters ( mean, range)
Weight in kg ( mean, range)
BMI (kg/m2)

Total household income level per
year ( number of people,
percentages)

Level of education
(n (%))

Employment status
(n (%))

Current anti-anxiety or antidepressant medications history
(n (%))
Primary cause of the symptoms
(n (%))

Part of body injured
(n (%))

Median
SD
Range
<$20000
$20000- $40000
$41000- $60000
$61000- $80000
$81000-$100000
$101000- $150000
$150000-$200000
> $200000
Did not finish school
High school
Community college
Trade school
University undergraduate degree
Master's degree
Doctorate
Others
Full-time
Part-time
Off work due to injury
Not employed for pay
People who were taking medications1
People who were not taking medications1

Value
40 (18 to 66)
46 (64.8%)
1.6 (1.4 to 1.9)
76.2 (43.6 to 136.3)
26.1
5.7
15.8 to 43.6
6 (8.1%)
9 (12.2%)
18 (24.3%)
8 (10.8%)
11 (14.9%)
18 (24.3%)
3 (4.1%)
1 (1.4%)
2 (2.7%)
19 (25.3%)
15 (20.0%)
7 (9.3%)
21 (28.0%)
8 (10.7%)
2 (2.7%)
1 (1.3%)
45 (60.0%)
12 (16.0%)
2 (2.7%)
16 (21.3%)
27 (35.5%)
49 (64.5%)

Motor vehicle accident
Pedestrian accident
Fall while on the level ground
Fall down a hill or stairs
Fall from a height
Hit by an object
Hit by another person( not while playing)
An awkward lift or twist
Hit by another person (while playing)
Neck
Shoulder
Elbow
Hand and Wrist
Lower back
Hip
Knee
Foot and Ankle

4 (5.5%)
1 (1.4%)
11(15.1%)
6 (8.2%)
1 (1.4%)
11 (15.1%)
1 (1.4%)
10 (13.7%)
2 (2.7%)
6 (7.9%)
10 (13.2%)
4 (5.3%)
10 (13.2%)
7 (9.2%)
1 (1.3%)
10 (13.2%)
19 (25.0%)

48

1

: Medications considered were anti-depressant or anti-anxiety drugs.

Table 3.2: Descriptive statistics of dependent and independent variables.
Tool
Adverse childhood
effect questionnaire
(ACE)
Acute stress disorder
scale (ASDS)

Brief pain inventoryshort form (BPI )

Traumatic injuries
distress scale ( TIDS)

Biomarkers of stress

1

Subscales
People who have no history of early life
adversity (29.7%)
People who endorsed at least 1 component
of the questionnaire (70.3%)
ASDS scale (Total, median(range))
Dissociation subscale (Total,
median(range))
Distress subscale (Total, median(range))
Pain intensity subscale(Total,
median(range))
Pain interference subscale(Total,
median(range))
Physical interference subscale(Total,
median(range))
Affective interference Subscale (Total,
median(range))
Sleep interference subscale (Total,
median(range))
Uncontrolled pain subscale(Total,
median(range))
Negative Affect subscale (Total,
median(range))
Hyper arousal subscale(Total,
median(range))
Total score of TIDS(Total, median(range))
Reference range
(pg/mL)
Cortisol
20,000 to 2,50,0001
BDNF
8000 to 46,0002
TGFB1
1000 to 33,000 3

Median (range)
0
3 (1 to 8)
95, 26 (19 to 67)
25, 6 (5 to 17)
70, 20 (14 to50)
40, 18.5 (3 to 32)
70, 29.5 (3 to 67)
30,16.5 (2 to30)
30, 4(0 to 18)
10, 4 ( 0 to 10)
8, 3 (0 to 8)
12, 2(0 to 12)
4, 0 ( 0 to 3)
24,6 (0 to 17)
Median pg/mL (range)
89,285 (21,270 to 3,59,60)
2,034.1 (422.08 to 10625.22)
20,313.5 (5428.9 to 59,122.7)

. Microcomputer Software Review Enzlab - - Elsevier Biosoft Synthetic Peptides in Biology and Medicine

Book Reviews Textbook of Clinical Chemistry, 1986
2.

Polacchini et al., 2015

3.

Kyrtsonis et al., 1998
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3.1.2

Hypothesis testing

3.1.2.1

Hypothesis 1: Exploring the influence of demographic variables
on stress markers

Table 3.3 shows the mean differences in stress biomarkers (cortisol, BDNF, TGFB1) when
the sample is split according to age, sex, BMI, education level, income level, medication
usage, and adverse childhood experiences. The only significant differences were in cortisol
(t (56) = 2.09; p = 0.04) and BDNF (t (54) = -1.92; p = 0.05) between the high and low
BMI groups. The high BMI group showed lower cortisol (279.9 vs.329.9 pg/mL) and
higher BDNF (52.2 vs.43.3 pg/mL) compared to the low BMI group. Differences between
all other groups and all TGFB1 comparisons did not reach statistical significance.

Table 3.3: Means (SD) of biomarkers split by key personal-level variables in the
acute setting of pain.
Variable
Age

40 or under (n = 36)
Over 40 (n=35)

BDNF
(pg/mL)
47.6 (18.1)
47.0 (19.6)

304.1 (97.7)
315.9 (86.8)

TGFB1
(pg/mL)
146.6 (40.9)
138.2 (37.4)

Cortisol (pg/mL)

Sex

Male (n = 25)
Female (n = 46)

47.3 (22.2)
47.4 (16.7)

308.7 (77.8)
310.5 (100.2)

132.2 (33.1)
148.1 (41.5)

BMI

≤26.1 kg/m2 (n = 31)
>26.1 kg/m2 (n = 31)

43.3 (15.0)
52.2 (19.5)

329.9 (105.7)
279.9 (73.8)

139.9 (40.6)
149.4 (41.6)

Group 1 (n = 48)
Group 2 (n = 22)
Meds2
No (n = 49)
Yes (n = 27)
Education3 Low (n = 37)
High (n = 38)
ACE4
None (n = 22)
At least 1 (n = 52)

49.7 (20.1)
44.1 (14.2)
47.3 (18.4)
49.8 (19.4)
46.3 (17.6)
49.9 (19.7)
48.8 (21.4)
48.1 (17.7)

311.8 (96.2)
316.5 (89.6)
320.4 (107.7)
299.5 (57.2)
316.2 (71.8)
310.3 (112.3)
293.5 (71.2)
309.4 (80.0)

147.8 (39.6)
139.4 (48.4)
139.7 (41.9)
157.2 (40.0)
139.0 (38.3)
151.7 (44.5)
144.3 (37.3)
146.0 (43.8)

Income1
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Bold: Differences between groups significant at the p ≤ 0.05 level
1. Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year
Income Group 2= > CDN$100,000 total household per year.
2: Medications considered were anti-depressant or anti-anxiety drugs.
3: High education = university undergraduate degree or higher
Low education = Trade school, community college, or no post-secondary education.
4: ACE = Adverse Childhood Experiences questionnaire.

Table 3.4 includes the differences in self-report measures of stress as measured by Acute
stress disorder scale(ASDS) following traumatic musculoskeletal injury when the sample
is split according to age, sex, BMI, education level, income level, medication usage, and
adverse childhood experiences. None of the differences were statistically significant.

Table 3.4: Means (SD) of scores of the Acute Stress Disorder Scale (ASDS) and
subscales split by key personal-level variables in the acute setting of pain.
Variable
Age
Sex
BMI
Income1
Medication2
Education3
ACE4

40 or under (n = 36)
Over 40 (n = 35)
Male (n = 25)
Female (n = 46)
≤ 26.1 kg/m2 (n = 31)
>26.1 kg/m2 (n = 31)
Group 1 (n = 48)
Group 2 (n = 22)
No (n = 48)
Yes (n = 23)
Low (n = 35)
High (n = 35)
None (n = 20)
At least 1 (n = 49)

Total ASDS
Score
26.7(8.7)
30.3 (11.5)
28.2 (11.3)
28.6 (9.6)
26.6 (9.3)
29.1 (9.4)
28.0 (8.6)
30.4(13.4)
28.2 (8.7)
29.1 (12.6)
27.5 (8.6)
29.7 (11.5)
28.7(10.4)
28.5 (10.1)

Distress
Subscale
20.4 (7.2)
22.6 (8.7)
21.5 (8.8)
21.4 (7.6)
20.3 (7.4)
21.5(6.8)
21.3 (6.8)
22.5 (10.3)
21.3 (7.1)
21.8 (9.2)
20.7 (6.9)
22.4 (8.7)
21.8 (8.2)
21.4 (7.8)

1. Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year
Income Group 2= > CDN$100,000 total household per year
2: Medications considered were anti-depressant or anti-anxiety drugs.
3: High education = university undergraduate degree or higher
Low education = Trade school, community college, or no post-secondary education.
4: ACE = Adverse Childhood Experiences questionnaire.

Dissociation
Subscale
6.4(2.3)
7.6 (3.4)
6.6 (2.9)
7.2(2.9)
6.3(2.7)
7.4 (2.9)
6.7 (2.4)
7.8(3.7)
6.8(2.5)
7.2 (3.4)
6.7 (2.4)
7.2 (3.2)
6.9 (2.9)
7.1 (2.9)
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Table 3.5 shows the differences in self-report measures of stress as measured by the Brief
Pain Inventory (BPI) following traumatic musculoskeletal injury when the sample is split
according to age, sex, BMI, education level, income level, medication usage, and adverse
childhood experiences. The only significant difference was in pain intensity by education,
where the low education group reported significantly higher pain intensity than the high
education group (t (65) =2.04, p =0.04).

Table 3.5: Mean (SD) of scores of the Brief Pain Inventory (short form) scale and
subscales Split by key personal-level variables in the acute setting of pain.
Variable
Age
40 or under (n = 34)
Over 40 (n = 32)
Sex
Male (n = 23)
Female (n = 43)
BMI
≤ 26.1 kg/m2 (n = 27)
>26.1 kg/m2 (n = 27)
Income1
Group1 (n = 51)
Group 2 (n = 18)
Medication2
No (n = 48)
Yes (n = 24)
Education3
Low (n = 35)
High (n = 35)
ACE4
None (n = 20)
At least 1 (n = 49)

Pain
intensity
Subscale

Pain
interference
Subscale

Physical
interference
Subscale

Affective
interference

Sleep
interference
Subscale

18.4(7.3)
17.6(7.8)

28.6 (16.3)
29.0 (16.6)

16.3 (7.7)
15.6 (7.9)

4.8 (4.9)
5.3 (4.7)

3.6 (2.9)
3.9(3.6)

18.5 (7.6)
17.8 (7.5)

30.5 (16.2)
27.9 (16.5)

15.6 (6.7)
16.2(8.3)

6.0(5.4)
4.5(4.4)

4.2 (3.1)
3.5 (3.3)

18.0 (7.3)
18.8 (6.6)

29.3(15.0)
30.9 (16.3)

16.3(6.9)
16.8 (7.8)

5.4 (4.5)
5.3 (4.8)

3.7 (3.1)
4.2 (3.2)

18.4 (6.9)
17.6 (8.6)

30.8 (16.6)
28.7(16.1)

16.9 (8.2)
15.1 (6.1)

5.2 (4.8)
5.7 (4.9)

4.2(3.1)
3.8 (3.5)

18.6 (7.6)
17.2 (6.7)

29.4 (15.4)
30.7 (18.5)

15.9 (7.3)
17.3(8.5)

5.3 (4.5)
4.9 (5.3)

3.9 (3.1)
4.1(3.5)

20.1 (6.9)
16.5 (7.3)

33.5 (16.7)
26.8 (15.5)

18.0(7.8)
15.1(7.3)

6.1 (5.0)
4.4 (4.5)

4.5 (3.2)
3.6 (3.2)

17.3 (8.3)
18.7 (6.9)

29.0 (14.9)
30.5(17.2 )

17.4 (7.8)
16.2 (7.8)

4.2 (3.8)
5.7 (5.2)

3.4 (3.1)
4.3 (3.3)

Bold: Differences between groups significant at the p < 0.05 level
1. Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year
Income Group 2= > CDN$100,000 total household per year
2: Medications considered were anti-depressant or anti-anxiety drugs.
3: High education = university undergraduate degree or higher
Low education = Trade school, community college, or no post-secondary education.
4: ACE = Adverse Childhood Experiences questionnaire.
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Table 3.6 represents the differences in self-report measures of stress as measured by
Traumatic Injuries Distress Scale (TIDS) following traumatic musculoskeletal injury when
the sample is split according to age, sex, BMI, education level, income level, medication
usage, and adverse childhood experiences. Those with income ≤ CDN $100,000 total
household per year scored higher on the negative affect subscale than those with income
>$100,000 (t (72) =2.19; p =0.03). Those taking medications for anxiety or depression
scored higher on the total TIDS score: t (72) = -3.47; p <0.01, the uncontrolled pain: t (72)
= -3.05; p <0.01and negative affect: t (73) = -3.24; p <0.01 subscales. Those with lower
education scored higher on the total score: t (62) = 2.56; p =0.01, negative affect subscale:
t (55) = 2.53; p =0.01 and hyper arousal subscale: t (52) = 2.97; p < 0.01.

Table 3.6: Mean (SD) of scores of the Traumatic Injuries Distress Scale (TIDS) scale
and subscales Split by key personal-level variables in the acute setting of pain.

Variable

Total

Uncontrolled
pain Subscale

Age
40 or under (n = 36)
Over 40 (n = 35)
Sex Male (n = 25)
Female (n = 45)
BMI
≤ 26.1 kg/m2 (n = 31)
>26.1 kg/m2 (n = 30)
Income1Group 1 (n = 52)
Group 2 (n = 22)
Medication2No (n = 48)
Yes (n = 27)
Education3 Low (n = 37)
High (n = 38)
ACE4None (n = 22)
At least 1 (n = 52)

5.8 (4.1)
5.8 (4.3)
5.5 (4.3)
5.9 (4.1)
6.1 (3.6)
5.6 (4.3)
6.4 (4.2)
4.9 (3.5)
4.8(3.8)
7.9(3.7)
7.1 (4.6)
4.7 (3.0)
4.7 (3.8)
6.5 (4.0)

2.9 (2.0)
3.1 (2.4)
2.6 (1.9)
3.1 (2.3)
3.2 (2.0)
2.6 (2.1)
3.1(2.1)
2.8 (2.1)
2.4(1.9)
3.9(2.1)
3.3 (2.2)
2.6 (1.9)
2.4 (2.2)
3.2 (2.0)

Negative
Affect
Subscale
2.8 (2.5)
2.6 (2.2)
2.7 (2.7)
2.7 (2.1)
2.7 (2.0)
2.8 (2.7)
3.2 (2.5)
1.9 (1.8)
2.2 (2.2)
3.9 (2.1)
3.4(2.8)
2.1(1.5)
2.3 (1.9)
3.0 (2.5)

Hyper
arousal
Subscale
0.4 (0.7)
0.2 (0.5)
0.4 (0.8)
0.2 (0.5)
0.2 (0.4)
0.4 (0.8)
0.3(0.7)
0.3(0.6)
0.3(0.6)
0.3(0.6)
0.5 (0.8)
0.1 (0.4)
0.3 (0.6)
0.3(0.7)
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Bold: Differences between groups significant at the p < 0.05 level
Italic: Differences between groups significant at the p < 0.01 level
. 1. Income Group 1 = CDN $100,000 or <CDN$100,000 total household per year
Income Group 2= > CDN$100,000 total household per year
2: Medications considered were anti-depressant or anti-anxiety drugs.
3: High education = university undergraduate degree or higher
Low education = Trade school, community college, or no post-secondary education.
4: ACE = Adverse Childhood Experiences questionnaire.

3.1.2.2

Hypothesis 2: Exploring the correlations between stress markers
following acute musculoskeletal injury

Table 3.7 provides correlations between biological and psychological markers of stress
following an acute stressful event. The association between cortisol and different selfreport measures of stress were significant at the p < 0.05 level (table 7). Cortisol showed
significant correlations with ASDS- total scores, ASDS- distress sub scale, BPI-pain
intensity, BPI- pain interference, BPI- affective and sleep interference sub scale scores and
TIDS- hyper arousal scores. BDNF was correlated negatively with BPI-physical
interference subscale scores. TGFB1 showed no significant correlations with the provided
scale scores in the acute setting of pain.
In the next step, Hierarchical regression was performed to assess the ability of self-report
measures of stress to predict the variance in cortisol and BDNF after controlling for BMI.
BMI was used as a continuous variable here. Table 3.8 contains the regression results. BPIpain intensity scores and TIDS- hyper arousal scores explained 13% and 8% variance in
cortisol respectively after controlling for BMI. 7% of the variance of BDNF was explained
by BPI-physical interference scale score after controlling the confounding effects of BMI.
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Table 3.7: Simple bivariate associations between key independent variables and
stress biomarkers in the acute stage of injury.
Cortisol (pg/mL)

ASDS-total subscale1
ASDS-distress
subscale1
ASDS-dissociation
subscale2
BPI-pain intensity
subscale1
BPI-pain interference
subscale1
BPI-physical
interference subscale1
BPI-affective
interference subscale1
BPI-sleep
interference
subscale2
TIDS-total score
subscale2
TIDS-uncontrolled
pain subscale2
TIDS- negative affect
subscale2
TIDS- hyper arousal
subscale2

BDNF (pg/mL)

TGFB1 (pg/mL)

r (p)
0.26 (0.04)

95% CI
0.03 to 0.45

r (p)
-0.19 (0.14)

95% CI
-0.38 to 0.03

r (p)
0.03 (0.83)

95% CI
-0.24 to 0.28

0.28(0.03)

0.05 to 0.49

-0.19(0.13)

-0.41 to 0.02

0.02 (0.87)

-0.23 to 0.26

0.13(0.30)

-0.13 to 0.37

-0.10 (0.41)

-0.31 to 0.10

0.20 (0.87)

-0.23 to 0.26

0.34(<0.01)

0.15 to 0.51

-0.03 (0.81)

-0.26 to 0.22

0.07 (0.60)

-0.17 to 0.31

0.28(0.02)

0.08 to 0.46

-0.14 (0.27)

-0.34 to 0.07

0.01 (0.94)

-0.25 to 0.27

0.24 (0.06)

0.02 to 0.44

-0.25 (0.04)

-0.45 to -0.03

0.01 (0.96)

-0.22 to 0.23

0.26(0.03)

0.08 to 0.46

-0.13(0.31)

-0.36 to 0.09

- 0.05 (0.69)

-0.28 to 0.19

0.26(0.03)

0.03 to 0.47

-0.03 (0.80)

-0.28 to 0.23

0.07 (0.56)

-0.21 to 0.34

-0.13 (0.30)

-0.37 to 0.13

0.01 (0.89)

-0.21 to 0.24

0.12 (0.34)

-0.12 to 0.34

0.09 (0.94)

-0.26 to 0.24

-0.02 (0.86)

-0.24 to 0.21

0.16 (0.19)

-0.06 to 0.38

-0.15 (0.21)

-0.43 to 0.13

0.03 (0.78)

-0.19 to 0.26

0.03 (0.78)

-0.20 to 0.25

-0.26 (0.03)

-0.49 to -0.01

0.15 (0.21)

-0.10 to 0.40

0.17 (0.17)

-0.07 to 0.39

Bold: Correlation is significant at the p < 0.05 level
Italic: Correlation is significant at the p < 0.01 level
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic injuries distress
scale.
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed.
2: Spearman's Rho (rho) is performed as the data are not normally distributed.

Table 3.8: Percentage of variance of cortisol and BDNF explained by self-reported
stress scores after controlling for BMI.
DV

IV

R2

∆r2

F

∆F

Cortisol
Cortisol
Cortisol
Cortisol
Cortisol
Cortisol
Cortisol
BDNF

ASDS- total score
ASDS- distress
BPI - pain intensity
BPI- pain interference
BPI- affective interference
BPI- sleep interference
TIDS- hyper arousal
BPI - physical interference

0.09
0.10
0.17
0.08
0.08
0.08
0.11
0.13

0.04
0.05
0.13
0.05
0.04
0.04
0.08
0.07

2.62
2.62
1.92
2.02
2.05
2.06
1.82
3.36

2.10
2.42
7.33
2.47
1.99
2.45
4.81
4.14

p (change in
F)
0.15
0.12
<0.01
0.12
0.16
0.12
0.03
0.04
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3.1.2.3

Hypothesis 3: Exploring the moderating effects of adverse
childhood experiences on the correlations between biological
and psychological variables in the acute pain setting.

The data were split according to adverse childhood experience endorsements into ACE and
NO ACE groups to explore potential differences in the magnitude and direction of
correlations between self-report tools and biomarkers of stress. There were differences in
the patterns of significant associations between the two groups. In the ACE group cortisol
showed significant positive correlations with BPI- pain intensity (r= 0.36), pain
interference (r = 0.36), physical interference (r = 0.35) and affective interference scores (r
= 0.31). In contrast, people who belong to no ACE group did not show such associations.
BDNF also showed significant negative associations with ASDS- total scores (r = -0.29)
and distress scores (r = -0.31) in ACE group only but not in the NO ACE group. The
associations between cortisol and ASDS- total scores (r =0.47) and distress (r = 0.49) were
significant in the NO ACE group only. BPI- sleep interference sub scale scores are
positively correlated with Cortisol (r = 0.53) and TGFB1 (r= 0.46) in the NO ACE group
only. The differences in correlation coefficient were significantly different between groups
in the cortisol x BPI Physical Interference, cortisol x BPI Affective interference, and
cortisol x BPI sleep interference, BDNF x ASDS- total, BDNF x ASDS- distress, TGFB1
x BPI sleep interference evaluations by virtue of point estimates for one group that lay
outside the 95% CI of the other group.
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All the significant associations are plotted in scatter plots to visualize the patterns of
associations between biological and psychological markers of stress in ACE and No ACE
group (Figures 3.1 to 3.9).
Table 3.9, 3.10 and 3.11 include the correlations between cortisol, BDNF, TGFB1 and selfreported measures of stress in the acute pain setting when the data is split according to the
history of adverse childhood effects.
Table 3.9: Simple bivariate associations between key independent variables and
cortisol in the acute stage of injury when the sample is split into two groups
according to the history of childhood adversities.
ACE (n=44)
Cortisol (pg/ml)
r(p)
0.23(0.15)

ASDS-total1
1

-0.07 to 0.48

NO ACE(n=19)
Cortisol (pg/ml)
r(P)
0.47* (0.05)

95 % CI

95% CI
-0.10 to 0.81

ASDS- distress
ASDS
dissociation1
BPI- pain intensity1

0.25 (0.12)
0.17 (0.28)

-0.05 to 0.53
-0.15 to 0.49

0.49*(0.04)
0.29 (0.22)

-0.02 to 0.79
-0.18 to 0.67

0.36*( 0.02)

0.16 to 0.56

0.28(0.25)

-0.13 to 0.61

BPI-pain
interference1
Physical
interference
subscale1
Affective
interference
subscale1
Sleep interference
subscale2
TIDS total score2

0.36 *(0.02)

0.12 to 0.46

0.14 (0.57)

-0.34 to 0.50

0.35*( 0.02)

0.08 to 0.57

0.01(0.96)

-0.50 to 0.41

0.31* (0.04)

0.07 to 0.51

0.06(0.79)

-0.35 to 0.48

0.19(0.21)

-0.09 to 0.46

0.53* (0.02)

0.11 to 0.78

-0.12 ( 0.45)

-0.37 to 0.18

-0.13 (0.57)

-0.61 to 0.26

-0.17 (0.25)
0.02 (0.90)
-0.23 (0.12)

-0.44 to 0.14
-0.26 to 0.31
-0.47 to 0.09

-0.24 (0.29)
-0.01 (0.98)
-0.29 (0.19)

-0.67 to 0.22
-0.52 to 0.47
-0.64 to 0.17

2

Negative affect
Uncontrolled pain2
Hyperarousal2

Bold: Correlation is significant at the p ≤ 0.05 level
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic Injuries Distress
Scale.
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed.
2: Spearman's Rho (rho) is performed as the data are not normally distributed.

BPI Pain Interferenece
Scale
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Figure 3.1: Scatter plot showing the linear relationships between plasma cortisol
and BPI-pain interference sub scale scores in ACE group and No ACE group. The
correlation between biological and psychological markers of stress is significant at
the p <0.05 level in ACE group.
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Figure 3.2: Scatter plot showing the linear relationships between plasma cortisol
and BPI-physical interference sub scale scores in ACE group and No ACE group
.The correlation between biological and psychological markers of stress is
significant at the p <0.05 level in ACE group.

Affective Interferenece Scale
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Figure 3.3: Scatter plot showing the linear relationships between plasma cortisol
and BPI-Affective interference sub scale scores in ACE group and No ACE group.
The correlation between biological and psychological markers of stress is significant
at the p <0.05 level in ACE group.
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Figure 3.4: Scatter plot showing the linear relationships between plasma cortisol
and BPI-sleep interference sub scale scores in ACE group and No ACE group. The
correlation between biological and psychological markers of stress is significant at
the p <0.05 level in No ACE group.
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Figure 3.5: Scatter plot showing the linear relationships between plasma cortisol
and ASDS scale scores (total) in ACE group and No ACE group. The correlation
between biological and psychological markers of stress is significant at the p ≤ 0.05
level in No ACE group.
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Figure 3.6: Scatter plot showing the linear relationships between plasma cortisol
and ASDS distress sub scale in ACE group and No ACE group. The correlation
between biological and psychological markers of stress is significant at the p <0.05
level in No ACE group.
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Table 3.10: Simple bivariate associations between key independent variables and
BDNF in the acute stage of injury when the sample is split into two groups
according to the history of childhood adversities.
ACE (n=46)

NO ACE(n=18)

BDNF(pg/ml)
95 % CI
r(p)
-0.29 (0.04)
-0.51 to -0.01

BDNF(pg/ml)
r(P)
0.08 (0.75)

-0.31 (0.04)

-0.49 to -0.04

0.06 (0.81)

-0.29 to 0.47

-0.19 (0.19)

-0.48 to 0.11

0.25 (0.31)

-0.31 to 0.81

-0.03 (0.84)

-0.35 to 0.27

-0.01 (0.98)

-0.44 to 0.49

-0.13 (0.39)

-0.41 to 0.14

-0.17 (0.50)

-0.53 to 0.18

-0.19 (0.19)

-0.42 to 0.03

-0.31 (0.21)

-0.62 to 0.03

-0.16 (0.29)

-0.45 to 0.15

-0.05 (0.85)

-0.46 to 0.36

-0.12 (0.44)

-0.39 to 0.24

0.08 (0.75)

-0.25 to 0.45

0.08 (0.58)

-0.17 to 0.34

-0.39 (0.10)

-0.82 to 0.17

Negative
affect2

0.09 (0.51)

-0.18 to 0.34

-0.29 (0.28)

-0.81 to 0.28

Uncontrolled
pain2

0.01 (0.92)

-0.24 to 0.26

-0.35 (0.15)

-0.76 to 0.27

Hyperarousal2 0.21 (0.14)

-0.08 to 0.47

-0.04 (0.86)

-0.57 to 0.49

ASDS-total1
ASDSdistress1
ASDS
dissociation1
BPI- pain
intensity1
BPI-pain
interference1
Physical
interference
subscale1
Affective
interference
subscale1
Sleep
interference
subscale2
TIDS total
score2

95% CI
-0.27 to 0.48

Bold: Correlation is significant at the p < 0.05 level
Italic: Correlation is significant at the p < 0.01 level
BDNF: Brain Derived Neurotrophic Factor.
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic Injuries Distress
Scale.
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed.
2: Spearman's Rho (rho) is performed as the data are not normally distributed.
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Figure 3.7: Scatter plot showing the linear relationships between plasma BDNF and
ASDS total score in ACE group and No ACE group. The correlation between
biological and psychological markers of stress is significant at the p <0.05 level in
ACE group.
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Figure 3.8: Scatter plot showing the linear relationships between plasma BDNF and
ASDS -distress sub scale scores in ACE group and No ACE group .The correlation
between biological and psychological markers of stress is significant at the p <0.05
level in ACE group.
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Table 3.11: Simple bivariate associations between key independent variables and
TGFB1 in the acute stage of injury when the sample is split into two groups
according to the history of childhood adversities.
ACE (n=45)

NO ACE(n=18)

TGFB1(pg/ml)
r(p)
-0.09 (0.56)

95 % CI

95% CI

-0.36 to 0.16

TGFB1(pg/ml)
r(p)
0.37 (0.16)

ASDSdistress1
ASDS
dissociation1
BPIpain
1
intensity
BPI-pain
interference1
Physical
interference
subscale1
Affective
interference
subscale1
Sleep
interference
subscale2
TIDS
total
score2

-0.10 (0.50)

-0.36 to 0.15

0.31 (0.13)

-0.42 to 0.78

-0.02 (0.86)

-0.27 to 0.19

0.18 (0.46)

-0.65 to 0.69

0.03 (0.87)

-0.27 to 0.32

0.18 (0.47)

-0.29 to 0.63

-0.05 (0.71)

-0.36 to 0.24

0.19 (0.43)

-0.22 to 0.56

-0.07 (0.62)

-0.34 to 0.20

0.19 (0.43)

-0.15 to 0.57

-0.08 (0.58)

-0.35 to 0.20

0.06 (0.79)

-0.44 to 0.47

-0.02 (0.91)

-0.34 to 0.30

0.46 (0.05)

-0.06 to 0.77

0.12 (0.41)

-0.14 to 0.37

0.22 (0.38)

-0.35 to 0.70

Negative
affect2

0.04 (0.78)

-0.24 to 0.31

0.15 (0.56)

-0.36 to 0.61

Uncontrolled
pain2

0.16 (0.28)

-0.13 to 0.41

0.28 (0.25)

-0.28 to 0.71

Hyperarousal2 0.18 (0.22)

-0.12 to 0.46

0.28 (0.25)

-0.29 to 0.71

ASDS-total1

-0.39 to 0.81

Bold: Correlation is significant at the p ≤ 0.05 level
TGFB1: Transforming Growth Factor Beta 1.
ASDS: Acute stress disorder scale, BPI (short form): Brief pain inventory, TIDS: Traumatic Injuries Distress
Scale.
1: Pearson's Correlation (r) is performed as the variables are approximately normally distributed.
2: Spearman's Rho (rho) is performed as the data are not normally distributed.
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Figure 3.9: Scatter plot showing the linear relationships between plasma TGFB1
and BPI -sleep interference sub scale scores in ACE group and No ACE group. The
correlation between biological and psychological markers of stress is significant at
the level p ≤ 0.05 in No ACE group.
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3.2 Discussions
This study examined the role of stress biomarkers in acutely traumatized patients to identify
the major stress markers that have the potential to serve as an intervention target to prevent
the development of chronic pain. The magnitude and direction of associations of cortisol
and BDNF with self-reported stress markers provided supportive evidence to support
further exploration of cortisol and BDNF as acute stress biomarkers. However, these results
need replication. The influence of the demographic variables on the acute stress markers
was investigated. It was found that BMI, education, income and medication usage were all
associated with the level of different stress markers (both biological and psychological).
The results of the study also supported a moderating role of adverse childhood experiences
on the relationships between biological and psychological stress markers following acute
trauma.
All of the major findings of the current study are discussed in the following section in
context of the existing literature.
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3.2.1

Demographic factors (age, sex, BMI, education, income level,
medication usage) that influence the level of stress following
acute non catastrophic musculoskeletal trauma.

3.2.1.1

Stress biomarkers and demographics

The current study found no significant differences in stress biomarkers between high and
low age groups. This finding is consistent with previous studies that reported no
differences in salivary and urinary cortisol levels between different age groups (Ceccato et
al., 2015; Ceccato et al., 2014).

However, some other studies reported significant

associations between older age and stress biomarkers. They reported increased level of
salivary cortisol level (Nicolson, Storms, Ponds, & Sulon, 1997) and decreased level of
plasma BDNF in older age groups (Lommatzsch et al., 2017). It has also been showed
that serum TGFB1 level was higher in low age groups in compared to adults (Okamoto et
al., 2005).It is worth noting that, in all these cases the differences in stress biomarkers level
between age groups were evaluated in healthy people. To the best of our knowledge, no
other studies have evaluated the age related differences in stress biomarkers in people who
survived a non-catastrophic musculoskeletal injury. Previous researchers have
recommended that in order to find the age related differences in cortisol level, it is
necessary to include participants who are more than 70 years of age in the sample (Nicolson
et al., 1997; Sapolsky & Plotsky, 1990). Due to the nature of the data, the present study
used 40 as a cut off score for age groups and the age range of this sample was 18 to 66
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years. This could be a reason for which no differences in stress markers between two age
groups were observed in the present study.
Many previous studies included the differences in stress biomarkers between males and
females (Larsson, Gullberg, Råstam, & Lindblad, 2009; Kajantie & Phillips, 2006). This
is in contrast with the current study that found no significant differences in any stress
biomarkers between males and females. However, the result was consistent with the study
that reported no significant differences in salivary cortisol level in males and females of
different age groups (Nicolson et al., 1997). Another study found no significant differences
in plasma BDNF level between males and females (Lommatzsch et al., 2017). According
to Paris and colleagues, the differences in cortisol level in males and females following
acute stressful condition depends on the types of the stress exposure (Paris et al., 2011). He
found higher cortisol level in men who survived a motor vehicle collision in comparison
to their female counterparts. On the other hand, in response to stressor like noise exposure
women showed higher cortisol level than men.
There were significant differences in biological markers (cortisol and BDNF) when the
sample was split by BMI. Previous studies have reported lower level of cortisol in obese
people (Odeniyi, Fasanmade, Ogbera, & Ohwovoriole, 2015 ; Travison T O’Donnell A
Araujo A Matsumoto A McKinlay J, 2007 ; Champaneri et al., 2013; Walker, Soderberg,
Lindahl, & Olsson, 2000). Travison et al. (2007) found a negative association between
cortisol concentration and all of their body composition parameters. This is consistent with
the findings of the present study. In contrast, the level of plasma BDNF was higher in the
high BMI group compared to the low BMI group which is supported by several other
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studies (Pillai et al., 2012; Liu et al., 2016; Fang et al., 2016). Many previous studies have
explored BDNF and BMI in people with major depressive disorder, Schizophrenia and
other mood disorders (Pillai et al., 2012). To the best of our knowledge, this is the first time
the level of BDNF was explored in high and low BMI people following a traumatic
musculoskeletal injury.

3.2.1.2

Psychological stress markers and demographics

The current study added to a growing body of literature that suggests "socioeconomic
status" as one of the non -modifiable risk factors for the development of chronic pain
conditions (van Hecke, Torrance, & Smith, 2013; Blyth, 2008; Poleshuck & Green, 2008).
Self-reported measures of stress were different in groups split according to the education
and income level of participants. The low education group reported greater pain intensity
after having a traumatic event. The level of overall acute distress as measured by TIDS
total score following trauma was also higher in the low education group. Several studies
reported the possible role of low education status in the development of chronic conditions
(Udom, Janwantanakul, & Kanlayanaphotporn, 2016 ; van Hecke et al., 2013; Dionne,
2001). To date however the mechanism has been unclear. This current study at least sheds
some light on this question, suggesting that lower education may lead to greater traumatic
distress.
The same pattern of result was also observed in people with income ≤ CDN$100,000 total
household per year. The mean score of this income group was higher on the Negative
Affect subscale of the TIDS compared to those with income > CDN $100,000 total
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household per year, which is indicative of more detachment or depressive symptoms. This
finding is consistent with other studies that also reported the role of perceived income
inadequacy as one of the causative factors in the development of chronic pain (Jordan,
Thomas, Peat, Wilkie, & Croft, 2008). According to the results of the current study, people
with income ≤ CDN$100,000 total household per year and comparatively low education
level report greater post-traumatic distress, which in turn may predispose them to greater
risk of chronic pain.
The presence of psychological co-morbidities such as depression and anxiety with chronic
pain conditions is well established by research (Holmes, Christelis, & Arnold, 2013; Banks,
Sara M.; Kerns, 1996; Hu et al., 2007) . However, the acute stress reaction in people who
have already diagnosed with depression or anxiety has not been explored to our knowledge.
This study hypothesized greater level of perceived stress in people who had depression or
anxiety disorders at the time of the traumatic event based on the findings of previous
research (Clauw & Chrousos, 1997; Breslau, GC, Andreski, & Peterson, 1991). The
findings of the study supported the hypothesis. Participants who self-reported current use
of anti- anxiety or anti- depressant drugs had higher level of overall distress, a lower sense
of pain control, and greater affective impairment as obtained by TIDS- total scale scores,
Negative affect sub scale scores and Uncontrolled pain subscale scores in comparison with
the scores of people who did not provide such medication history. While the mechanisms
are unclear from this study, these results suggest that it will be important to control for preexisting psychological comorbidity in future studies of trauma, stress and pain.
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3.2.2

Potential stress biomarkers and their associations with selfreport measures of stress

The current study investigated the relationships between perceived stress and biomarkers
of stress in people who experienced a non-catastrophic musculoskeletal injury. The
positive correlations of cortisol with self-reported post traumatic distress can be considered
as supportive evidence for cortisol as an acute stress biomarker. Self-reported
psychological distress, perceived pain intensity and disabilities associated with pain
showed statistically significant positive associations with cortisol.
The current study found that self-reported pain intensity score predicted 13% of the
variance in cortisol after controlling for the confounding effects of demographic variable (
p<0.01). Walton et al. (2013b) found a significant positive correlation between pain
catastrophizing and hair normalized salivary cortisol in participants who underwent a
traumatic injury. Positive associations between salivary cortisol and heightened pain
intensity/pain catastrophizing were also evident in the experimental pain setting (Quartana
et al., 2010Jones, Rollman, & Brooke, 1997). Perceived high pain intensity in the
immediate aftermath of trauma has been suggested as one of the consistent predictors of
chronic pain development (Walton et al., 2013a; Quartana, Campbell, & Edwards, 2009;
Bortsov et al., 2014). As cortisol showed positive relation with higher pain intensity and
previous research supported the idea that the stress system is capable of influencing pain
processing (McLean et al., 2005); regulation of cortisol following trauma may hold
promise as an intervention target to prevent the development of chronic conditions.
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However, this relationship should be investigated further to reach any definitive conclusion
considering the limited sample size and cross-sectional nature of the study.
In the current study, self-reported hyper arousal subscale score predicted 8% of the
variance in cortisol after controlling for the confounding effects of demographic variable
(p < 0.05). Hyper arousal is referred to as a state which is characterized by difficulty to fall
asleep and wakefulness because of enhanced physical, emotional and cognitive arousal
(Kay & Buysse, 2017).Hyper arousal after trauma was suggested as a strong indicator of
chronic conditions like Post traumatic stress disorder (PTSD) , Whiplash associated
disorder(WAD) and Chronic pain (Andersen, Elklit, & Vase, 2011; Liedl & Knaevelsrud,
2008 ; Liedl et al., 2010). It has been demonstrated by a longitudinal study that the people
who identified "acute hyper arousal " as a prominent symptom following a traumatic event
are more likely develop chronic PTSD symptoms than who included hyper arousal as a less
prominent one (Schell, T. L., Marshall, G. N., & Jaycox, 2004). Interestingly, PTSD and
recovery from trauma also appeared to be dependent on each other (Sterling, Hendrikz, &
Kenardy, 2010). Further longitudinal studies are necessary to elucidate the mechanism of
associations between hyper arousal and the PTSD and their subsequent role in the
development of chronic pain.
One of the new additions of this study was to explore BDNF as an acute stress marker after
a traumatic event. BDNF showed significant negative association with physical
interference subscale score. In this study, self-reported physical disability as a result of
trauma explained 7% of the variance in BDNF after controlling for the confounding effects
of demographic variable (p < 0.05). It has been reasonably well established that exercise
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and physical activity can lead to increased BDNF levels in the brain (Vaynman, Ying, &
Gomez-Pinilla, 2004; Ding et al., 2004; Schmolesky, Webb, & Hansen, 2013) that has
potentially important neuroprotective function. According to Nijs and colleagues , high
BDNF level may reduce the likelihood of chronic pain development due to its crucial role
against maladaptive neuroplasticity which is the reason underlying many chronic pain
conditions (Nijs et al., 2015). The current study suggests an association between self-rated
interference in physical function and plasma BDNF level, but the clinical importance of
this association requires further exploration.
The current study also explored the role of TGFB1 as an acute stress biomarker. TGFB1
was found not to be associated with any of the self-reported values. This is in contrast to
previous findings. Previous studies regarded TGFB1 as potential biomarker for conditions
like temporomandibular joint tenderness and osteoarthritis(Slade et al., 2011;Shen, Li, &
Chen, 2014). However no studies had investigated the role of TGFB1 in the acute pain
condition. It is probable that the role of TGFB1 may become more prevalent in chronic
pain conditions rather than in the acute pain setting. This relationship should be explored
further to reach a definitive conclusion.

3.2.3

The moderating role of adverse childhood experiences on the
associations between biological and psychological indictors of
stress in the acute pain setting

Considerable amount of research studies have focused on the effects of adverse childhood
experiences as it has emerged as an important indicator of adult health and well-being(De
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Bellis & Zisk, 2014; Vincent J Felitti & Anda, 2010). The current study investigated the
role of adverse childhood experiences (ACE) in the acute pain setting to understand its
interplay with other stress markers in acute pain and distress.
People who have endorsed at least one component of the ACE scale were considered as
the “ACE group” in this study. In the ACE group, cortisol showed significant positive
correlations with the BPI pain intensity score and almost all of the subscale scores of BPI.
Previous studies reported a relationship between heightened perceived pain intensity and
childhood adversities (Drevin et al., 2015; Sansone,Watts, & Wiederman, 2013).Existing
evidence suggests that the most consistent predictors of chronic pain development are high
initial pain intensity, self-reported psychological distress and activity interference(Walton
et al., 2013a ; McLean et al., 2005). It is noteworthy that all of these variables (as measured
by BPI- pain intensity subscale, physical and affective interference subscale) were
positively correlated with cortisol only in the people who endorsed adverse childhood
experiences. This association maybe partially explained by the dysregulation of biological
stress system in people with ACE. Earlier research suggested that early life adversity
increases endocrine and autonomic responses to stress (Anacker, O’Donnell, & Meaney,
2014). It has also been proposed that childhood adversities lead to persistent HPA axis
dysregulation via an epigenetic mechanism (McGowan, 2013) that may preferentially
influence the stress-response pathways. Therefore it can be proposed that people who
experienced childhood adversities may react to subsequent stressful events differently than
those with no such exposure, likely due to a complex interplay of both psychological and
physiological processes. However, this result should be interpreted with caution because
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of the limited sample size, exploratory, cross-sectional nature of the study and retrospective
measure of the adverse childhood experiences.
BDNF was negatively correlated with ASDS- total score and ASDS- distress subscale
score in the ACE group only. People who develop acute stress disorder following a
traumatic event are more likely to develop PTSD in later life(Harvey & Bryant, 2002).
From the results of the current study, high BDNF may protect against acute stress disorder,
or acute stress disorder may lower levels of BDNF. Lower BDNF level was associated with
higher ASDS scores only in the subsample who had history of adverse childhood
experiences. This is in line with the studies that suggested the stressful childhood
experiences can reduce the BDNF level in a subset of the population (Vollmayr, Faust,
Lewicka, & Henn, 2001; Daskalakis, De Kloet, Yehuda, Malaspina, & Kranz, 2015).
Lower BDNF level has also been implicated in the development of several chronic
conditions such as depression, bipolar disorder, chronic widespread pain (Elzinga et al.,
2011; Fernandes et al., 2015 ; Caumo et al., 2016). It has been shown that direct infusion
of BDNF resulted in improvement of symptoms despite of high level of circulating
corticosterone in a study that investigated stressed rodents (Lakshminarasimhan &
Chattarji, 2012). These findings point to a possible interplay between cortisol, BDNF and
psychologically perceived stress level in the acute pain setting that may suggest a new
target for intervention to prevent chronic pain.
There were only 19 people on the No ACE group, leading to wide confidence limits for
many correlations and very few significant associations beyond ASDS- total score x
cortisol and ASDS- distress subscale score x cortisol. No other psychological markers
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were related to cortisol in the no ACE group. BDNF showed no significant correlations
with any of the stress variables. The Sleep interference subscale of the BPI was positively
correlated with cortisol and TGFB1 in the No ACE group only. There are inconsistencies
regarding the role of cortisol in sleep disturbances. Some studies found increased level of
evening cortisol and increased cortisol awakening response in people with sleep
disturbances (Kumari et al., 2009). Others reported decreased cortisol awakening response
with sleep disturbances (Backhaus, Junghanns, & Hohagen, 2004) . This study found that
increased plasma cortisol is associated with increased self-reported sleep disturbances but
data on the cortisol awakening response is not yet available. Sleep disturbances are
frequently associated with cytokines namely Interleulin-1(IL- 1) and Tumor necrosis factor
(TNF) and it has been hypothesized that other cytokines may play a role in the development
of sleep related maladies(Krueger, 2008). To the best of our knowledge this is the first
study that reported an association between TGFB1 and sleep interference. The current
study revealed that those who scored higher on the BPI sleep interference subscale had
higher level of TGFB1. In the ACE group, cortisol and TGFB1 showed no associations
with sleep interference scale scores. The mechanisms to explain these findings are unclear
but it would appear that early life adversity moderates the association between self-reported
distress and stress biomarkers that should be considered in the design of future studies in
this area.
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Chapter 4

4

Conclusions and Recommendations

This study supported the promising role of cortisol and BDNF as acute intervention targets
following trauma for the prevention of chronic pain development. It can also be proposed
from the results of the study that that people who experienced childhood adversities may
react to subsequent stressful events differently than those with no such exposure, likely due
to a complex interplay of both psychological and physiological processes which in turn
may predispose to chronic pain development. However, several limitations of this study
should be taken into consideration when interpreting the results.

4.1 Limitations and future directions
The study had a small sample size. According to my findings, if I wanted to fully explore
the association between cortisol and negative affect in people with no adverse childhood
experiences (correlation magnitude of 0.24), desiring 80% power and accepting a 5% alpha
error rate, 99 subjects would be required (Faul, Erdfelder, Lang, & Buchner, 2007).
Replicating the results using a larger sample is necessary. Generalizability of these findings
may be limited due to the specific setting of the study along with the small sample size.
This study only focused on the people who survived a minor traumatic event.
As the study was cross sectional in nature, it was not able to indicate any causal
relationship. More information is needed to reach any conclusions based on the results of
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the study. In the future, similar research should be conducted with follow up at a regular
basis to determine the complex nature of the biological and psychological markers of pain.
Childhood adverse effects were assessed retrospectively by ACE questionnaire. Though
the ACE questionnaire is a widely used and reliable tool to diagnose early life adversities,
the chance of memory bias is not to be ignored. Furthermore, the participants were
categorized dichotomously. The participants who scored 1 to 8 were considered as ACE
group. It is possible that the people who scored higher (4 to 8), perceived stressful
conditions differently than the people who had moderate (1 to 3) childhood adverse
experiences. Different types of maltreatment (physical, sexual and emotional abuse,
parental separation, death of a parent in childhood) could have different influences on stress
biomarkers that were not examined separately in the present study. All these factors should
be evaluated separately to find out the modifying role of childhood adversities on stress
markers. This needs to be addressed in the future research.
The impact of daily life stressors was not assessed in the current study. Current life stressors
may influence the biomarkers which is a direction for additional research in the future.
In this study, the serum cortisol level was determined in those people who presented to the
emergency department between 10 am to 5 pm with a history of non-catastrophic
musculoskeletal injuries. After obtaining consent, blood was drawn to measure stress
biomarkers level. Cortisol secretion varies throughout the day. The diurnal secretion of
cortisol and the resulting variation in serum cortisol concentration made the interpretation
of a single cortisol value of the current study problematic. There may be variations in
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cortisol concentration in people who showed up in the emergency department at different
times of day. Venipuncture itself can results in the rise of cortisol level. All these factors
should be kept in mind while evaluating the results of the current study.
This study used serum BDNF level which may not be a direct measure of central BDNF
level, although a strong correlation has been observed between central and peripheral
BDNF level in animal studies (Karege, Schwald, & Cisse, 2002). An interesting topic for
the future studies could be the evaluation of the correlations between central and peripheral
BDNF level in humans.
By considering the preliminary stage of this study, caution was taken while identifying
outliers and removing them. It is possible that some outliers on a specific scale may
represent an interesting subset of the population which could not be explored at this time,
due to the limited sample size. However, the figures represented the relationships between
stress markers (included in the result section) confirmed evenly distribution of scores. It is
possible that few existing outliers could affect the relations dramatically. Hence, Additional
work is warranted before interpreting the results of the study.

4.2 Conclusions
In summary, the current study provided tentative evidence for plasma cortisol and BDNF
as acute stress biomarkers that appear to be associated with some aspects of post-traumatic
pain and distress. Cortisol in particular was correlated with several perceived stress scores.
The influence of demographic variables on both biological and psychological stress
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markers provided supportive evidence to be considered in the design of future traumarelated pain studies. The associations between the stress markers in people who endorsed
a history of childhood adversities provided preliminary support for the modifying effects
of the adverse childhood effects on individuals’ reactions to a stressful condition in
adulthood. These findings point to a possible interplay between stress biomarkers,
psychologically perceived stress level, demographic and socio-economic status and early
life stress in the acute pain setting that may suggest a new target for intervention to prevent
chronic pain. These associations need to be explored further to better understand the
influence of acute distress on pain and the subsequent development of chronic problems.
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